<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="blood"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC4304112/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304112/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Blood"><meta name="citation_title" content="A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults"><meta name="citation_authors" content="Virginia Perez-Andreu, Kathryn G. Roberts, Heng Xu, Colton Smith, Hui Zhang, Wenjian Yang, Richard C. Harvey, Debbie Payne-Turner, Meenakshi Devidas, I-Ming Cheng, William L. Carroll, Nyla A. Heerema, Andrew J. Carroll, Elizabeth A. Raetz, Julie M. Gastier-Foster, Guido Marcucci, Clara D. Bloomfield, Krzysztof Mrózek, Jessica Kohlschmidt, Wendy Stock, Steven M. Kornblau, Marina Konopleva, Elisabeth Paietta, Jacob M. Rowe, Selina M. Luger, Martin S. Tallman, Michael Dean, Esteban G. Burchard, Dara G. Torgerson, Feng Yue, Yanli Wang, Ching-Hon Pui, Sima Jeha, Mary V. Relling, William E. Evans, Daniela S. Gerhard, Mignon L. Loh, Cheryl L. Willman, Stephen P. Hunger, Charles G. Mullighan, Jun J. Yang"><meta name="citation_date" content="22 January 2015"><meta name="citation_issue" content="4"><meta name="citation_volume" content="125"><meta name="citation_firstpage" content="680"><meta name="citation_doi" content="10.1182/blood-2014-09-595744"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC4304112/?report=abstract"><meta name="citation_pmid" content="25468567"><meta name="DC.Title" content="A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="The American Society of Hematology"><meta name="DC.Contributor" content="Virginia Perez-Andreu"><meta name="DC.Contributor" content="Kathryn G. Roberts"><meta name="DC.Contributor" content="Heng Xu"><meta name="DC.Contributor" content="Colton Smith"><meta name="DC.Contributor" content="Hui Zhang"><meta name="DC.Contributor" content="Wenjian Yang"><meta name="DC.Contributor" content="Richard C. Harvey"><meta name="DC.Contributor" content="Debbie Payne-Turner"><meta name="DC.Contributor" content="Meenakshi Devidas"><meta name="DC.Contributor" content="I-Ming Cheng"><meta name="DC.Contributor" content="William L. Carroll"><meta name="DC.Contributor" content="Nyla A. Heerema"><meta name="DC.Contributor" content="Andrew J. Carroll"><meta name="DC.Contributor" content="Elizabeth A. Raetz"><meta name="DC.Contributor" content="Julie M. Gastier-Foster"><meta name="DC.Contributor" content="Guido Marcucci"><meta name="DC.Contributor" content="Clara D. Bloomfield"><meta name="DC.Contributor" content="Krzysztof Mrózek"><meta name="DC.Contributor" content="Jessica Kohlschmidt"><meta name="DC.Contributor" content="Wendy Stock"><meta name="DC.Contributor" content="Steven M. Kornblau"><meta name="DC.Contributor" content="Marina Konopleva"><meta name="DC.Contributor" content="Elisabeth Paietta"><meta name="DC.Contributor" content="Jacob M. Rowe"><meta name="DC.Contributor" content="Selina M. Luger"><meta name="DC.Contributor" content="Martin S. Tallman"><meta name="DC.Contributor" content="Michael Dean"><meta name="DC.Contributor" content="Esteban G. Burchard"><meta name="DC.Contributor" content="Dara G. Torgerson"><meta name="DC.Contributor" content="Feng Yue"><meta name="DC.Contributor" content="Yanli Wang"><meta name="DC.Contributor" content="Ching-Hon Pui"><meta name="DC.Contributor" content="Sima Jeha"><meta name="DC.Contributor" content="Mary V. Relling"><meta name="DC.Contributor" content="William E. Evans"><meta name="DC.Contributor" content="Daniela S. Gerhard"><meta name="DC.Contributor" content="Mignon L. Loh"><meta name="DC.Contributor" content="Cheryl L. Willman"><meta name="DC.Contributor" content="Stephen P. Hunger"><meta name="DC.Contributor" content="Charles G. Mullighan"><meta name="DC.Contributor" content="Jun J. Yang"><meta name="DC.Date" content="2015 Jan 22"><meta name="DC.Identifier" content="10.1182/blood-2014-09-595744"><meta name="DC.Language" content="en"><meta property="og:title" content="A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults"><meta property="og:type" content="article"><meta property="og:description" content="Acute lymphoblastic leukemia (ALL) in adolescents and young adults (AYA) is characterized by distinct presenting features and inferior prognosis compared with pediatric ALL. We performed a genome-wide association study (GWAS) to comprehensively identify ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304112/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-blood.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC4304112/epub/">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8CBD33DD57B0810000000002E101CB.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-3"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4304112%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=%22Blood%22[journal]" class="navlink">Blood</a></li><li class="accid">PMC4304112</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-blood.gif" alt="Logo of blood" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="139,56,200,76" alt="Original Article" title="Original Article" href="http://www.bloodjournal.org/content/125/4/680" ref="reftype=publisher&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CBanner&amp;TO=Publisher%7CArticle%7CFullText" target="pmc_ext"><area shape="rect" coords="0,0,157,57" alt="Blood Journal" title="Blood Journal" href="http://www.bloodjournal.org/" ref="reftype=publisher&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="200,56,258,76" alt="Current Issue" title="Current Issue" href="http://www.bloodjournal.org/content/current" ref="reftype=publisher&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="257,56,311,76" alt="About Blood" title="About Blood" href="http://www.bloodjournal.org/page/about-blood" ref="reftype=publisher&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="309,56,364,77" alt="Submissions" title="Submissions" href="https://submit.bloodjournal.org/" ref="reftype=publisher&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="363,56,420,78" alt="Subscriptions" title="Subscriptions" href="http://www.bloodjournal.org/page/subscriptions" ref="reftype=publisher&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="418,56,476,76" alt="Contact Us" title="Contact Us" href="http://bloodjournal.org" ref="reftype=publisher&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="poly" coords="450,2,431,9,425,27,429,43,437,54,459,55,471,52,483,42,486,29,479,11,466,2,449,2" alt="ASH Homepage" title="ASH Homepage" href="http://www.hematology.org" ref="reftype=publisher&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Blood</a></span>. 2015 Jan 22; 125(4): 680–686. </span></div><div><span class="fm-vol-iss-date">Prepublished online 2014 Dec 2. </span>  <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1182%2Fblood-2014-09-595744" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1182/blood-2014-09-595744</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC4304112</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/25468567">25468567</a></div></div></div></div><h1 class="content-title">A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Perez-Andreu%20V%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629807456016" co-class="co-affbox">Virginia Perez-Andreu</a>,<sup>1</sup> <a href="/pubmed/?term=Roberts%20KG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629808462960" co-class="co-affbox">Kathryn G. Roberts</a>,<sup>2</sup> <a href="/pubmed/?term=Xu%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629800544208" co-class="co-affbox">Heng Xu</a>,<sup>1,</sup><sup>3</sup> <a href="/pubmed/?term=Smith%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629808664064" co-class="co-affbox">Colton Smith</a>,<sup>1</sup> <a href="/pubmed/?term=Zhang%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629808662080" co-class="co-affbox">Hui Zhang</a>,<sup>1</sup> <a href="/pubmed/?term=Yang%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629806685680" co-class="co-affbox">Wenjian Yang</a>,<sup>1</sup> <a href="/pubmed/?term=Harvey%20RC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629807559472" co-class="co-affbox">Richard C. Harvey</a>,<sup>4</sup> <a href="/pubmed/?term=Payne-Turner%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629807557488" co-class="co-affbox">Debbie Payne-Turner</a>,<sup>2</sup> <a href="/pubmed/?term=Devidas%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629806710912" co-class="co-affbox">Meenakshi Devidas</a>,<sup>5</sup> <a href="/pubmed/?term=Cheng%20IM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629804778080" co-class="co-affbox">I-Ming Cheng</a>,<sup>6</sup> <a href="/pubmed/?term=Carroll%20WL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629807233072" co-class="co-affbox">William L. Carroll</a>,<sup>7</sup> <a href="/pubmed/?term=Heerema%20NA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629807231088" co-class="co-affbox">Nyla A. Heerema</a>,<sup>8</sup> <a href="/pubmed/?term=Carroll%20AJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629807671584" co-class="co-affbox">Andrew J. Carroll</a>,<sup>9</sup> <a href="/pubmed/?term=Raetz%20EA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629807161568" co-class="co-affbox">Elizabeth A. Raetz</a>,<sup>10</sup> <a href="/pubmed/?term=Gastier-Foster%20JM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629807159584" co-class="co-affbox">Julie M. Gastier-Foster</a>,<sup>11</sup> <a href="/pubmed/?term=Marcucci%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629806366768" co-class="co-affbox">Guido Marcucci</a>,<sup>12</sup> <a href="/pubmed/?term=Bloomfield%20CD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629878096240" co-class="co-affbox">Clara D. Bloomfield</a>,<sup>12</sup> <a href="/pubmed/?term=Mr%26%23x000f3%3Bzek%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629878094256" co-class="co-affbox">Krzysztof Mrózek</a>,<sup>12</sup> <a href="/pubmed/?term=Kohlschmidt%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629803435952" co-class="co-affbox">Jessica Kohlschmidt</a>,<sup>12,</sup><sup>13</sup> <a href="/pubmed/?term=Stock%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629810698848" co-class="co-affbox">Wendy Stock</a>,<sup>14</sup> <a href="/pubmed/?term=Kornblau%20SM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629810131984" co-class="co-affbox">Steven M. Kornblau</a>,<sup>15</sup> <a href="/pubmed/?term=Konopleva%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629810130000" co-class="co-affbox">Marina Konopleva</a>,<sup>16</sup> <a href="/pubmed/?term=Paietta%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629807023168" co-class="co-affbox">Elisabeth Paietta</a>,<sup>17</sup> <a href="/pubmed/?term=Rowe%20JM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629799815152" co-class="co-affbox">Jacob M. Rowe</a>,<sup>18</sup> <a href="/pubmed/?term=Luger%20SM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629799813168" co-class="co-affbox">Selina M. Luger</a>,<sup>19</sup> <a href="/pubmed/?term=Tallman%20MS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629878274608" co-class="co-affbox">Martin S. Tallman</a>,<sup>20</sup> <a href="/pubmed/?term=Dean%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629844775632" co-class="co-affbox">Michael Dean</a>,<sup>21</sup> <a href="/pubmed/?term=Burchard%20EG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629802086480" co-class="co-affbox">Esteban G. Burchard</a>,<sup>22</sup> <a href="/pubmed/?term=Torgerson%20DG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629802084608" co-class="co-affbox">Dara G. Torgerson</a>,<sup>22</sup> <a href="/pubmed/?term=Yue%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629805468368" co-class="co-affbox">Feng Yue</a>,<sup>23</sup> <a href="/pubmed/?term=Wang%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629806864880" co-class="co-affbox">Yanli Wang</a>,<sup>23</sup> <a href="/pubmed/?term=Pui%20CH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629806863008" co-class="co-affbox">Ching-Hon Pui</a>,<sup>24</sup> <a href="/pubmed/?term=Jeha%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629801192608" co-class="co-affbox">Sima Jeha</a>,<sup>24</sup> <a href="/pubmed/?term=Relling%20MV%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629879375664" co-class="co-affbox">Mary V. Relling</a>,<sup>1</sup> <a href="/pubmed/?term=Evans%20WE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629879373680" co-class="co-affbox">William E. Evans</a>,<sup>1</sup> <a href="/pubmed/?term=Gerhard%20DS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629799972464" co-class="co-affbox">Daniela S. Gerhard</a>,<sup>25</sup> <a href="/pubmed/?term=Loh%20ML%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629806052800" co-class="co-affbox">Mignon L. Loh</a>,<sup>26</sup> <a href="/pubmed/?term=Willman%20CL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629806050816" co-class="co-affbox">Cheryl L. Willman</a>,<sup>6</sup> <a href="/pubmed/?term=Hunger%20SP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629800042992" co-class="co-affbox">Stephen P. Hunger</a>,<sup>27</sup> <a href="/pubmed/?term=Mullighan%20CG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629802588656" co-class="co-affbox">Charles G. Mullighan</a>,<sup>2</sup> and  <a href="/pubmed/?term=Yang%20JJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567" class="affpopup" co-rid="_co_idm139629802586672" co-class="co-affbox">Jun J. Yang</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author"></sup><sup>1</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139629807456016"><h3 class="no_margin">Virginia Perez-Andreu</h3><p><sup>1</sup>Department of Pharmaceutical Sciences and </p><div>Find articles by <a href="/pubmed/?term=Perez-Andreu%20V%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Virginia Perez-Andreu</a></div></div><div id="_co_idm139629808462960"><h3 class="no_margin">Kathryn G. Roberts</h3><p><sup>2</sup>Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN; </p><div>Find articles by <a href="/pubmed/?term=Roberts%20KG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Kathryn G. Roberts</a></div></div><div id="_co_idm139629800544208"><h3 class="no_margin">Heng Xu</h3><p><sup>1</sup>Department of Pharmaceutical Sciences and </p><p><sup>3</sup>State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu, China; </p><div>Find articles by <a href="/pubmed/?term=Xu%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Heng Xu</a></div></div><div id="_co_idm139629808664064"><h3 class="no_margin">Colton Smith</h3><p><sup>1</sup>Department of Pharmaceutical Sciences and </p><div>Find articles by <a href="/pubmed/?term=Smith%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Colton Smith</a></div></div><div id="_co_idm139629808662080"><h3 class="no_margin">Hui Zhang</h3><p><sup>1</sup>Department of Pharmaceutical Sciences and </p><div>Find articles by <a href="/pubmed/?term=Zhang%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Hui Zhang</a></div></div><div id="_co_idm139629806685680"><h3 class="no_margin">Wenjian Yang</h3><p><sup>1</sup>Department of Pharmaceutical Sciences and </p><div>Find articles by <a href="/pubmed/?term=Yang%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Wenjian Yang</a></div></div><div id="_co_idm139629807559472"><h3 class="no_margin">Richard C. Harvey</h3><p><sup>4</sup>University of New Mexico Cancer Center, Albuquerque, NM; </p><div>Find articles by <a href="/pubmed/?term=Harvey%20RC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Richard C. Harvey</a></div></div><div id="_co_idm139629807557488"><h3 class="no_margin">Debbie Payne-Turner</h3><p><sup>2</sup>Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN; </p><div>Find articles by <a href="/pubmed/?term=Payne-Turner%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Debbie Payne-Turner</a></div></div><div id="_co_idm139629806710912"><h3 class="no_margin">Meenakshi Devidas</h3><p><sup>5</sup>Department of Biostatistics, Colleges of Medicine, Public Health &amp; Health Professions, University of Florida, Gainesville, FL; </p><div>Find articles by <a href="/pubmed/?term=Devidas%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Meenakshi Devidas</a></div></div><div id="_co_idm139629804778080"><h3 class="no_margin">I-Ming Cheng</h3><p><sup>6</sup>Cancer Research and Treatment Center, University of New Mexico, Albuquerque, NM; </p><div>Find articles by <a href="/pubmed/?term=Cheng%20IM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">I-Ming Cheng</a></div></div><div id="_co_idm139629807233072"><h3 class="no_margin">William L. Carroll</h3><p><sup>7</sup>Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY; </p><div>Find articles by <a href="/pubmed/?term=Carroll%20WL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">William L. Carroll</a></div></div><div id="_co_idm139629807231088"><h3 class="no_margin">Nyla A. Heerema</h3><p><sup>8</sup>Department of Pathology, College of Medicine, The Ohio State University, Columbus, OH; </p><div>Find articles by <a href="/pubmed/?term=Heerema%20NA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Nyla A. Heerema</a></div></div><div id="_co_idm139629807671584"><h3 class="no_margin">Andrew J. Carroll</h3><p><sup>9</sup>Department of Genetics, University of Alabama at Birmingham, Birmingham, AL; </p><div>Find articles by <a href="/pubmed/?term=Carroll%20AJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Andrew J. Carroll</a></div></div><div id="_co_idm139629807161568"><h3 class="no_margin">Elizabeth A. Raetz</h3><p><sup>10</sup>Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT; </p><div>Find articles by <a href="/pubmed/?term=Raetz%20EA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Elizabeth A. Raetz</a></div></div><div id="_co_idm139629807159584"><h3 class="no_margin">Julie M. Gastier-Foster</h3><p><sup>11</sup>The Ohio State University, Nationwide Children’s Hospital, Columbus, OH; </p><div>Find articles by <a href="/pubmed/?term=Gastier-Foster%20JM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Julie M. Gastier-Foster</a></div></div><div id="_co_idm139629806366768"><h3 class="no_margin">Guido Marcucci</h3><p><sup>12</sup>Comprehensive Cancer Center, The Ohio State University, Columbus, OH; </p><div>Find articles by <a href="/pubmed/?term=Marcucci%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Guido Marcucci</a></div></div><div id="_co_idm139629878096240"><h3 class="no_margin">Clara D. Bloomfield</h3><p><sup>12</sup>Comprehensive Cancer Center, The Ohio State University, Columbus, OH; </p><div>Find articles by <a href="/pubmed/?term=Bloomfield%20CD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Clara D. Bloomfield</a></div></div><div id="_co_idm139629878094256"><h3 class="no_margin">Krzysztof Mrózek</h3><p><sup>12</sup>Comprehensive Cancer Center, The Ohio State University, Columbus, OH; </p><div>Find articles by <a href="/pubmed/?term=Mr%26%23x000f3%3Bzek%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Krzysztof Mrózek</a></div></div><div id="_co_idm139629803435952"><h3 class="no_margin">Jessica Kohlschmidt</h3><p><sup>12</sup>Comprehensive Cancer Center, The Ohio State University, Columbus, OH; </p><p><sup>13</sup>Alliance of Clinical Trials in Oncology Statistics and Data Center, Mayo Clinic, Rochester; </p><div>Find articles by <a href="/pubmed/?term=Kohlschmidt%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Jessica Kohlschmidt</a></div></div><div id="_co_idm139629810698848"><h3 class="no_margin">Wendy Stock</h3><p><sup>14</sup>Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL; </p><div>Find articles by <a href="/pubmed/?term=Stock%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Wendy Stock</a></div></div><div id="_co_idm139629810131984"><h3 class="no_margin">Steven M. Kornblau</h3><p><sup>15</sup>Section of Molecular Hematology &amp; Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX; </p><div>Find articles by <a href="/pubmed/?term=Kornblau%20SM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Steven M. Kornblau</a></div></div><div id="_co_idm139629810130000"><h3 class="no_margin">Marina Konopleva</h3><p><sup>16</sup>The University of Texas MD Anderson Cancer Center, Houston, TX; </p><div>Find articles by <a href="/pubmed/?term=Konopleva%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Marina Konopleva</a></div></div><div id="_co_idm139629807023168"><h3 class="no_margin">Elisabeth Paietta</h3><p><sup>17</sup>Department of Medicine (Oncology), Albert Einstein College of Medicine, Yeshiva University, New York, NY; </p><div>Find articles by <a href="/pubmed/?term=Paietta%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Elisabeth Paietta</a></div></div><div id="_co_idm139629799815152"><h3 class="no_margin">Jacob M. Rowe</h3><p><sup>18</sup>Rambam Medical Center, Haifa, Israel; </p><div>Find articles by <a href="/pubmed/?term=Rowe%20JM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Jacob M. Rowe</a></div></div><div id="_co_idm139629799813168"><h3 class="no_margin">Selina M. Luger</h3><p><sup>19</sup>Hematologic Malignancies Program, Hematology-Oncology Division, University of Pennsylvania, Philadelphia, PA; </p><div>Find articles by <a href="/pubmed/?term=Luger%20SM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Selina M. Luger</a></div></div><div id="_co_idm139629878274608"><h3 class="no_margin">Martin S. Tallman</h3><p><sup>20</sup>Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; </p><div>Find articles by <a href="/pubmed/?term=Tallman%20MS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Martin S. Tallman</a></div></div><div id="_co_idm139629844775632"><h3 class="no_margin">Michael Dean</h3><p><sup>21</sup>Laboratory of Experimental Immunology, National Cancer Institute, Frederick, MD; </p><div>Find articles by <a href="/pubmed/?term=Dean%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Michael Dean</a></div></div><div id="_co_idm139629802086480"><h3 class="no_margin">Esteban G. Burchard</h3><p><sup>22</sup>Department of Bioengineering &amp; Therapeutic Science and Department of Medicine, University of California, San Francisco, San Francisco, CA; </p><div>Find articles by <a href="/pubmed/?term=Burchard%20EG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Esteban G. Burchard</a></div></div><div id="_co_idm139629802084608"><h3 class="no_margin">Dara G. Torgerson</h3><p><sup>22</sup>Department of Bioengineering &amp; Therapeutic Science and Department of Medicine, University of California, San Francisco, San Francisco, CA; </p><div>Find articles by <a href="/pubmed/?term=Torgerson%20DG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Dara G. Torgerson</a></div></div><div id="_co_idm139629805468368"><h3 class="no_margin">Feng Yue</h3><p><sup>23</sup>Department of Biochemistry and Molecular Biology, Pennsylvania State University College of Medicine, Hershey, PA; </p><div>Find articles by <a href="/pubmed/?term=Yue%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Feng Yue</a></div></div><div id="_co_idm139629806864880"><h3 class="no_margin">Yanli Wang</h3><p><sup>23</sup>Department of Biochemistry and Molecular Biology, Pennsylvania State University College of Medicine, Hershey, PA; </p><div>Find articles by <a href="/pubmed/?term=Wang%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Yanli Wang</a></div></div><div id="_co_idm139629806863008"><h3 class="no_margin">Ching-Hon Pui</h3><p><sup>24</sup>Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN; </p><div>Find articles by <a href="/pubmed/?term=Pui%20CH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Ching-Hon Pui</a></div></div><div id="_co_idm139629801192608"><h3 class="no_margin">Sima Jeha</h3><p><sup>24</sup>Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN; </p><div>Find articles by <a href="/pubmed/?term=Jeha%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Sima Jeha</a></div></div><div id="_co_idm139629879375664"><h3 class="no_margin">Mary V. Relling</h3><p><sup>1</sup>Department of Pharmaceutical Sciences and </p><div>Find articles by <a href="/pubmed/?term=Relling%20MV%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Mary V. Relling</a></div></div><div id="_co_idm139629879373680"><h3 class="no_margin">William E. Evans</h3><p><sup>1</sup>Department of Pharmaceutical Sciences and </p><div>Find articles by <a href="/pubmed/?term=Evans%20WE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">William E. Evans</a></div></div><div id="_co_idm139629799972464"><h3 class="no_margin">Daniela S. Gerhard</h3><p><sup>25</sup>Office of Cancer Genomics, National Cancer Institute, Bethesda, MD; </p><div>Find articles by <a href="/pubmed/?term=Gerhard%20DS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Daniela S. Gerhard</a></div></div><div id="_co_idm139629806052800"><h3 class="no_margin">Mignon L. Loh</h3><p><sup>26</sup>Department of Pediatrics and the Helen Diller Family Cancer Center, University of California, San Francisco, San Francisco, CA; and </p><div>Find articles by <a href="/pubmed/?term=Loh%20ML%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Mignon L. Loh</a></div></div><div id="_co_idm139629806050816"><h3 class="no_margin">Cheryl L. Willman</h3><p><sup>6</sup>Cancer Research and Treatment Center, University of New Mexico, Albuquerque, NM; </p><div>Find articles by <a href="/pubmed/?term=Willman%20CL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Cheryl L. Willman</a></div></div><div id="_co_idm139629800042992"><h3 class="no_margin">Stephen P. Hunger</h3><p><sup>27</sup>School of Medicine and Children’s Hospital, University of Colorado School of Medicine, Aurora, CO</p><div>Find articles by <a href="/pubmed/?term=Hunger%20SP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Stephen P. Hunger</a></div></div><div id="_co_idm139629802588656"><h3 class="no_margin">Charles G. Mullighan</h3><p><sup>2</sup>Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN; </p><div>Find articles by <a href="/pubmed/?term=Mullighan%20CG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Charles G. Mullighan</a></div></div><div id="_co_idm139629802586672"><h3 class="no_margin">Jun J. Yang</h3><p><sup>1</sup>Department of Pharmaceutical Sciences and </p><div>Find articles by <a href="/pubmed/?term=Yang%20JJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25468567">Jun J. Yang</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139629801832624_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139629801832624_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139629801832624_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139629801832624_ai" style="display:none"><div class="fm-affl" id="aff1" lang="en"><sup>1</sup>Department of Pharmaceutical Sciences and </div><div class="fm-affl" id="aff2" lang="en"><sup>2</sup>Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN; </div><div class="fm-affl" id="aff3" lang="en"><sup>3</sup>State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu, China; </div><div class="fm-affl" id="aff4" lang="en"><sup>4</sup>University of New Mexico Cancer Center, Albuquerque, NM; </div><div class="fm-affl" id="aff5" lang="en"><sup>5</sup>Department of Biostatistics, Colleges of Medicine, Public Health &amp; Health Professions, University of Florida, Gainesville, FL; </div><div class="fm-affl" id="aff6" lang="en"><sup>6</sup>Cancer Research and Treatment Center, University of New Mexico, Albuquerque, NM; </div><div class="fm-affl" id="aff7" lang="en"><sup>7</sup>Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY; </div><div class="fm-affl" id="aff8" lang="en"><sup>8</sup>Department of Pathology, College of Medicine, The Ohio State University, Columbus, OH; </div><div class="fm-affl" id="aff9" lang="en"><sup>9</sup>Department of Genetics, University of Alabama at Birmingham, Birmingham, AL; </div><div class="fm-affl" id="aff10" lang="en"><sup>10</sup>Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT; </div><div class="fm-affl" id="aff11" lang="en"><sup>11</sup>The Ohio State University, Nationwide Children’s Hospital, Columbus, OH; </div><div class="fm-affl" id="aff12" lang="en"><sup>12</sup>Comprehensive Cancer Center, The Ohio State University, Columbus, OH; </div><div class="fm-affl" id="aff13" lang="en"><sup>13</sup>Alliance of Clinical Trials in Oncology Statistics and Data Center, Mayo Clinic, Rochester; </div><div class="fm-affl" id="aff14" lang="en"><sup>14</sup>Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL; </div><div class="fm-affl" id="aff15" lang="en"><sup>15</sup>Section of Molecular Hematology &amp; Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX; </div><div class="fm-affl" id="aff16" lang="en"><sup>16</sup>The University of Texas MD Anderson Cancer Center, Houston, TX; </div><div class="fm-affl" id="aff17" lang="en"><sup>17</sup>Department of Medicine (Oncology), Albert Einstein College of Medicine, Yeshiva University, New York, NY; </div><div class="fm-affl" id="aff18" lang="en"><sup>18</sup>Rambam Medical Center, Haifa, Israel; </div><div class="fm-affl" id="aff19" lang="en"><sup>19</sup>Hematologic Malignancies Program, Hematology-Oncology Division, University of Pennsylvania, Philadelphia, PA; </div><div class="fm-affl" id="aff20" lang="en"><sup>20</sup>Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; </div><div class="fm-affl" id="aff21" lang="en"><sup>21</sup>Laboratory of Experimental Immunology, National Cancer Institute, Frederick, MD; </div><div class="fm-affl" id="aff22" lang="en"><sup>22</sup>Department of Bioengineering &amp; Therapeutic Science and Department of Medicine, University of California, San Francisco, San Francisco, CA; </div><div class="fm-affl" id="aff23" lang="en"><sup>23</sup>Department of Biochemistry and Molecular Biology, Pennsylvania State University College of Medicine, Hershey, PA; </div><div class="fm-affl" id="aff24" lang="en"><sup>24</sup>Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN; </div><div class="fm-affl" id="aff25" lang="en"><sup>25</sup>Office of Cancer Genomics, National Cancer Institute, Bethesda, MD; </div><div class="fm-affl" id="aff26" lang="en"><sup>26</sup>Department of Pediatrics and the Helen Diller Family Cancer Center, University of California, San Francisco, San Francisco, CA; and </div><div class="fm-affl" id="aff27" lang="en"><sup>27</sup>School of Medicine and Children’s Hospital, University of Colorado School of Medicine, Aurora, CO</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author"></sup>Corresponding author.</div><div id="idm139629806578096">V.P.-A., K.G.R., and H.X. contributed equally to this study.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm139629801832624_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2014 Aug 31; Accepted 2014 Nov 13.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm139629801832624_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC4304112/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm139629809571568" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139629809571568title">Key Points</h2><!--article-meta--><div><ul class="unordered" style="list-style-type:disc"><!--
list-behavior=unordered
prefix-word=
mark-type=disc
max-label-size=0
--><li><p id="__p3">In this first ALL GWAS in AYAs, we determined that inherited <em>GATA3</em> variants strongly influence ALL susceptibility in this age group.</p></li><li><p id="__p4">These findings revealed similarities and differences in the genetic basis of ALL susceptibility between young children and AYAs.</p></li></ul><p></p></div></div><div id="idm139629799510944" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139629799510944title">Abstract</h2><!--article-meta--><div><p id="__p5" class="p p-first-last">Acute lymphoblastic leukemia (ALL) in adolescents and young adults (AYA) is characterized by distinct presenting features and inferior prognosis compared with pediatric ALL. We performed a genome-wide association study (GWAS) to comprehensively identify inherited genetic variants associated with susceptibility to AYA ALL. In the discovery GWAS, we compared genotype frequency at 635 297 single nucleotide polymorphisms (SNPs) in 308 AYA ALL cases and 6,661 non-ALL controls by using a logistic regression model with genetic ancestry as a covariate. SNPs that reached <em>P</em> ≤ 5 × 10<sup>−8</sup> in GWAS were tested in an independent cohort of 162 AYA ALL cases and 5,755 non-ALL controls. We identified a single genome-wide significant susceptibility locus in <em>GATA3</em>: rs3824662, odds ratio (OR), 1.77 (<em>P</em> = 2.8 × 10<sup>−10</sup>) and rs3781093, OR, 1.73 (<em>P</em> = 3.2 × 10<sup>−9</sup>). These findings were validated in the replication cohort. The risk allele at rs3824662 was most frequent in Philadelphia chromosome (Ph)-like ALL but also conferred susceptibility to non–Ph-like ALL in AYAs. In 1,827 non-selected ALL cases, the risk allele frequency at this SNP was positively correlated with age at diagnosis (<em>P</em> = 6.29 × 10<sup>−11</sup>). Our results from this first GWAS of AYA ALL susceptibility point to unique biology underlying leukemogenesis and potentially distinct disease etiology by age group.</p></div></div><div id="__sec1" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec1title">Introduction</h2><p id="__p6" class="p p-first">Cancer survival rates have been steadily increasing in the United States across age groups except for in adolescents and young adults (AYA; age 16 to 39 years), partly because of the persisting inferior treatment response in hematologic malignancies.<sup><a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885164">1</a></sup> Particularly with acute lymphoblastic leukemia (ALL), age as a continuous variable is negatively correlated with prognosis in spite of risk-adapted combination chemotherapy.<sup><a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885170">2</a></sup> In an analysis of 21 626 ALL cases diagnosed between 1990 and 2005 and treated on Children’s Oncology Group (COG) frontline protocols, survival rates decreased significantly with increasing age at diagnosis regardless of treatment era (eg, 94.1% for age 1 to 10, 84.7% for age 10 to 15, and 75.9% for age 15 to 22 years in the 2000-2005 cohort).<sup><a href="#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885154">3</a></sup> Although pediatric-based treatment regimens have been tested in AYA populations and have resulted in improved survival, the gap in treatment outcome between age groups persists, and ALL remains one of the leading causes of cancer-related deaths in the AYA population.<sup><a href="#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885184">4</a>,<a href="#B5" rid="B5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885151">5</a></sup></p><p id="__p7">The inferior prognosis of AYA is likely to be multifactorial and includes socioeconomic factors, medication adherence, clinical trial enrollment and, importantly, age-related differences in ALL tumor and host biology.<sup><a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885182">6</a></sup> For example, as age increases, there is a progressive rise in prevalence of ALL genetic subtypes with poor prognosis such as Philadelphia chromosome–positive (Ph+),<sup><a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885158">7</a></sup> Ph-like,<sup><a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885132">8</a></sup> or intrachromosomal amplification of chromosome 21,<sup><a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885150">9</a></sup> whereas subtypes with favorable outcome (high hyperdiploidy<sup><a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885163">10</a></sup> and <em>ETV6-RUNX1</em><sup><a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_469442008">11</a></sup>) become less common. These comparisons are informative but are also limited because they are primarily driven by ALL features discovered in children and/or older adults. As a result, differences in tumor biology between AYA and childhood ALL may have been underestimated, and genomic profiling studies focusing on the AYAs are likely to reveal novel molecular features unique to this population.</p><p id="__p8">Inherited genetic variations can strongly influence both the susceptibility to ALL<sup><a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_559043395">12</a><a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885175"></a><a href="#B14" rid="B14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885142"></a>-<a href="#B15" rid="B15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885143">15</a></sup> and treatment outcomes.<sup><a href="#B16" rid="B16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885152">16</a><a href="#B17" rid="B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885141"></a><a href="#B18" rid="B18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885135"></a><a href="#B19" rid="B19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885165"></a>-<a href="#B20" rid="B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885149">20</a></sup> For example, genome-wide association studies (GWASs) have identified germline genetic variants at <em>ARID5B</em>, <em>IKZF1</em>, <em>CEBPE</em>, <em>PIP4K2A</em>, and <em>CDKN2A/CDKN2B</em> loci with substantial cumulative effects on ALL disease risk in children. These ALL susceptibility genes are involved in lymphoid cell development, cell cycle control, and tumor suppression, collectively affecting leukemogenesis. Although one’s inherited genetic variants remain unchanged over a lifetime, it is possible that the effects of these susceptibility variants vary by age, thus contributing to the age-related differences in ALL incidence and subtype. In fact, when we examined the risk of ALL conferred by the <em>ARID5B</em> variant, there was a clear trend of diminishing effects with increasing age (ie, allelic odds ratio of 2.01, 1.8, and 1.48 in children younger than age 5, 5 to 10, and older than 10 years, respectively).<sup><a href="#B15" rid="B15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885144">15</a></sup> However, germline variants related to ALL risk in the AYA population have not been comprehensively examined.</p><p id="__p9" class="p p-last">To better understand the potential unique leukemia etiology in AYAs, we conducted the first GWAS to systemically interrogate germline single nucleotide polymorphisms (SNPs) for their contribution to ALL risk in this age group.</p></div><div id="__sec2" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec2title">Methods</h2><div id="__sec3" class="sec sec-first"><h3 id="__sec3title">Study design and patients</h3><p id="__p10" class="p p-first">In the discovery GWAS, the ALL cases consisted of 209 adolescents (median age, 17.4 years; range, 16 to 21 years) and 99 young adults (median age, 24.3 years; range, 21 to 39 years) with newly diagnosed B-cell ALL who were treated on the Children’s Oncology Group (COG; N = 202),<sup><a href="#B21" rid="B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885137">21</a></sup> the Alliance-Cancer and Leukemia Group B (N = 56),<sup><a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885174">22</a></sup> Eastern Cooperative Oncology Group E2993 (N = 29),<sup><a href="#B23" rid="B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885191">23</a></sup> MD Anderson Cancer Center (N = 11) <sup><a href="#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885178">24</a><a href="#B25" rid="B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885159"></a><a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885162"></a>-<a href="#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885171">27</a></sup>, and St. Jude Children’s Research Hospital (N = 10) trials.<sup><a href="#B28" rid="B28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885133">28</a></sup> The subjects were chosen on the basis of the availability of germline DNA, which was extracted from peripheral blood samples during clinical remission (&lt;5% blasts cells in bone marrow). A total of 6,661 unrelated subjects from the Multi-Ethnic Study of Atherosclerosis (MESA) cohort (dbGaP phs000209.v9) were considered as non-ALL control subjects because the prevalence of adult survivors of childhood ALL is extremely low.<sup><a href="#B14" rid="B14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885155">14</a></sup></p><p id="__p11">For the replication analyses, 162 children with ALL age 16 to 21 years from the COG P9900 protocols (COG P9905 [<a id="__tag_559043398" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00005596" ref="reftype=extlink-clinical-trial&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00005596","term_id":"NCT00005596"}}</span>NCT00005596</a>], COG P9904 [<a id="__tag_559043396" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00005585" ref="reftype=extlink-clinical-trial&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00005585","term_id":"NCT00005585"}}</span>NCT00005585</a><sup><a href="#B29" rid="B29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885127">29</a></sup>], COG P9906 [<a id="__tag_559043397" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00005603" ref="reftype=extlink-clinical-trial&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00005603","term_id":"NCT00005603"}}</span>NCT00005603</a><sup><a href="#B30" rid="B30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885153">30</a></sup>], and COG AALL0232 [<a id="__tag_559043399" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00075725" ref="reftype=extlink-clinical-trial&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00075725","term_id":"NCT00075725"}}</span>NCT00075725</a><sup><a href="#B21" rid="B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885180">21</a></sup>]) were included. A set of 5755 unrelated non-ALL controls were included in the replication analysis: 1228 African Americans (AAs) from the AIDS Linked to Intravenous Experience (ALIVE) cohort,<sup><a href="#B31" rid="B31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885134">31</a></sup> 880 Hispanic Americans from the Genetics of Asthma in Latino Americans (GALA) study,<sup><a href="#B32" rid="B32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885130">32</a></sup> and 3647 European Americans (EAs) from the Genetic Association Informative Network (GAIN) schizophrenia cohort (dbGAP phs000021.v3.p2)<sup><a href="#B33" rid="B33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885147">33</a></sup> and GAIN bipolar cohort (phs000017.v3.p1<sup><a href="#B34" rid="B34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885172">34</a></sup>; <a href="/pmc/articles/PMC4304112/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC4304112/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139629810825552" class="figure"><a href="/pmc/articles/PMC4304112/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4304112_680f1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is 680f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC4304112/bin/680f1.jpg"></a></div><div id="largeobj_idm139629810825552" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4304112/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC4304112/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p12"><strong>GWAS study design.</strong> ALL susceptibility variants were identified by comparing SNP genotype frequency in AYA ALL cases compared with non-ALL controls in the discovery GWAS, followed by replication. CALGB: The Alliance-Cancer and Leukemia Group B; COG: Children’s Oncology Group; ECOG: Eastern Cooperative Oncology Group; MDACC: MD Anderson Cancer Center; SJ: St. Jude Children’s Research Hospital.</p></div></div></div><p id="__p13" class="p p-last">The clinical trials were approved by local institutional review boards, and informed consent for trial enrollment and banking of specimens for future research was obtained from parents, guardians, or patients, as appropriate. This study was approved by the St. Jude Children’s Research Hospital institutional review board.</p></div><div id="__sec4" class="sec"><h3 id="__sec4title">Genotyping and quality control</h3><p id="__p14" class="p p-first">Genome-wide SNP genotyping was performed by using the Affymetrix Human SNP Array 6.0 for ALL cases in the discovery GWAS, those in the COG P9905, P9904, and AALL0232 cohorts, and for all non-ALL controls (dbGaP MESA, ALIVE, GAIN, and GALA). Genotype calls (coded as 0, 1, and 2 for AA, AB, and BB genotypes) were determined by the Birdseed v2 (Affymetrix SNP 6.0) algorithm.<sup><a href="#B35" rid="B35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885138">35</a></sup> Samples for which genotypes were ascertained for less than 95% of SNPs on the array were deemed to have failed and were excluded from the analyses. For the ALL cases in the COG P9906 trial, genome-wide SNP genotyping was performed by using Affymetrix Human SNP Array 500K, and <em>GATA3</em> SNPs were genotyped by polymerase chain reaction and Sanger sequencing, as described previously.<sup><a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885157">36</a></sup> We did not observe evidence of potential genotyping errors in the germline DNA because of tumor cell contamination (data not shown).</p><p id="__p15" class="p p-last">Prior to GWAS, SNPs were subjected to a series of quality control steps (supplemental Figure 1, available on the <em>Blood</em> Web site). First, we filtered SNPs on the basis of minor allele frequency (MAF) and SNP call rate: for SNPs with an MAF of 1% to 3%, we excluded those with a call rate &lt;99%; for SNPs with an MAF of 3% to 5%, we excluded those with a call rate &lt;98%; for SNPs with an MAF of &gt;5%, we excluded those with a call rate &lt;95%. An additional filtering step was applied in the GWAS involving non-ALL controls: we removed SNPs for which genotype frequencies differed significantly among control groups (ie, dbGaP MESA vs HapMap unrelated CEU or dbGaP MESA <em>vs</em> the GAIN bipolar cohort [dbGaP phs000017.v3]<sup><a href="#B33" rid="B33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885168">33</a></sup>; <em>P</em> &lt; 10<sup>−6</sup> by χ<sup>2</sup> test), and the comparison was restricted to EAs. Finally, those SNPs deviating from Hardy-Weinberg equilibrium (<em>P</em> &lt; .01 in EA cases or controls) were also excluded from the analysis. After quality control filters were applied, 635 297 SNPs were included in the GWAS.</p></div><div id="__sec5" class="sec"><h3 id="__sec5title">Genetic ancestry and population structure</h3><p id="__p16" class="p p-first">Genetic ancestry was determined by using STRUCTURE (version 2.2.3),<sup><a href="#B37" rid="B37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885128">37</a></sup> based on genotypes at 30 000 SNPs randomly selected from the Affymetrix SNP arrays. HapMap samples from descendants of Northern Europeans (CEU; N = 60), West Africans (YRI; N = 60), East Asians (CHB/JPT; N = 90), and Native Americans (NAs; N = 105)<sup><a href="#B38" rid="B38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885160">38</a></sup> references were used to represent European, African, Asian, and Native American ancestries, respectively. We assumed that these four ancestries summed to 100% in each genotyped individual. EAs, AAs, NAs, and Asians were defined as having &gt;95% European genetic ancestry, &gt;70% African ancestry, &gt;90% NA ancestry, and &gt;90% Asian ancestry, respectively. Hispanics were individuals for whom NA ancestry was &gt;10% and greater than African ancestry (including genetically defined NAs). The rest of the subjects were grouped as “Others.”</p><p id="__p17" class="p p-last">We also performed principal component analysis of ALL cases and controls in the discovery GWAS cohort, including all SNPs that passed the quality control and observed comparable population structure between cases and controls (supplemental Figure 2). In addition, we exhaustively examined potential relatedness within ALL cases and within controls included in the discovery GWAS by computing pairwise identity by descent probabilities. No evidence of first or second-degree relationships was identified.</p></div><div id="__sec6" class="sec"><h3 id="__sec6title">ALL somatic genomic lesions</h3><p id="__p18" class="p p-first-last">In the discovery cohort, the ALL genetic subtypes included high hyperdiploid (&gt;50 chromosomes), <em>ETV6-RUNX1</em>, <em>TCF3-PBX1</em>, <em>MLL</em>-rearranged, <em>BCR-ABL1</em> (Ph<sup>+</sup>), and Ph-like (with or without <em>CRLF2</em> rearrangements). Ph-like and <em>ERG</em>-deregulated ALL were defined by Predictive Analysis of Microarrays.<sup><a href="#B21" rid="B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885179">21</a>,<a href="#B39" rid="B39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885186">39</a></sup> In the COG P9900 series, ALL subtypes included <em>ETV6-RUNX1</em>, <em>TCF3-PBX1</em>, hyperdiploid, and <em>MLL</em>-rearranged, with the remainder of cases considered as B-other. <em>GATA3</em> expression was quantified in 237 ALL blasts in 237 AYA cases, using Affymetrix U133A array.<sup><a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885166">8</a></sup></p></div><div id="__sec7" class="sec sec-last"><h3 id="__sec7title">Statistical analysis</h3><p id="__p19" class="p p-first">In the discovery GWAS, the association test between genotypes at each of the 635 297 SNPs and ALL susceptibility was tested by comparing genotype frequency between AYA ALL cases and non-ALL controls using a logistic regression test under an additive model, including European, African, and NA ancestry (as continuous variables) as covariates using PLINK (v1.07).<sup><a href="#B40" rid="B40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885177">40</a></sup> Population stratification was assessed by the construction of a quantile-quantile plot (supplemental Figure 3), and there was only a minimal inflation at the upper tail of the distribution (λ = 1.02). SNPs that reached the association <em>P</em> ≤ 5 × 10<sup>−8</sup> in the discovery GWAS were evaluated in the independent replication series (1-tailed test). In both discovery and replication groups, we also tested <em>GATA3</em> SNPs separately in EAs, AAs, and Hispanic Americans.</p><p id="__p20" class="p p-last">R (version 2.15.1) statistical software was used for the rest of the analyses unless indicated otherwise. Statistical tests were chosen as appropriate and according to the phenotype distribution (eg, normally or binomially distributed for continuous or categorical variables, respectively). Associations of SNP genotype with somatic lesions and age were estimated by logistic regression and linear regression test, respectively, after adjusting for genetic ancestry. Associations of <em>GATA3</em> SNP genotype with <em>GATA3</em> gene expression was assessed by linear regression model, adjusting for genetic ancestry.</p></div></div><div id="__sec8" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec8title">Results</h2><div id="__sec9" class="sec sec-first"><h3 id="__sec9title">AYA ALL GWAS</h3><p id="__p21" class="p p-first">In the discovery GWAS, we compared genotype frequency at 635 297 SNPs between 308 AYA ALL cases and 6,661 non-ALL controls (<a href="/pmc/articles/PMC4304112/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>). After adjusting for genetic ancestry, only two SNPs at 10p14 within the <em>GATA3</em> gene reached genome-wide significance: rs3824662 (odds ratio [OR], 1.77; 95% confidence interval [CI], 1.48 to 2.12; <em>P</em> = 2.84 × 10<sup>−10</sup>) and rs3781093 (OR, 1.73; 95% CI, 1.44 to 2.08; <em>P</em> = 3.20 × 10<sup>−9</sup>; <a href="/pmc/articles/PMC4304112/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a> and <a href="/pmc/articles/PMC4304112/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>). These two SNPs were in strong linkage disequilibrium (<em>r</em><sup>2</sup> = 0.94; D′ = 1 in HapMap CEU; supplemental Figure 4), representing a single susceptibility locus. The A allele at rs3824662 was significantly overrepresented in ALL cases compared with controls (35% vs 20%) and was consistent across race/ethnicity (ie, EAs, 30% vs 17% [<em>P</em> = 1.09 × 10<sup>−5</sup>]; Hispanics, 50% vs 33% [<em>P</em> = .0008]; and AAs, 20% vs 10% [<em>P</em> = .07]; <a href="/pmc/articles/PMC4304112/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3A</span></a>). rs3781093 was significantly associated with ALL risk in EAs and Hispanics, but not in individuals of African descent in whom it was no longer in linkage disequilibrium (<em>r</em><sup>2</sup> = 0.006; D′ = 0.16) with rs3824662 (supplemental Figure 5A).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p22">Association of <em>GATA3</em> SNPs with AYA ALL susceptibility in the discovery GWAS and replication cohort</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139629876590304" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="bottom"><tr><th rowspan="2" colspan="1">Chr</th><th rowspan="2" colspan="1" align="center">Position<sup>*</sup></th><th rowspan="2" colspan="1" align="center">SNP</th><th rowspan="2" colspan="1" align="center">Alleles<sup>†</sup></th><th rowspan="2" colspan="1" align="center">Cohort</th><th rowspan="2" colspan="1" align="center">RAF<sup>§</sup> in AYA cases (%)</th><th colspan="3" rowspan="1" align="center">Genotype count in cases<sup>‡</sup></th><th rowspan="2" colspan="1" align="center">RAF<sup>§</sup> in non-ALL controls (%) </th><th colspan="3" rowspan="1" align="center">Genotype count in controls<sup>‡</sup></th><th colspan="3" rowspan="1" align="center">AYA ALL vs non-ALL</th></tr><tr><th rowspan="1" colspan="1" align="center">RR</th><th rowspan="1" colspan="1" align="center">RW</th><th rowspan="1" colspan="1" align="center">WW</th><th rowspan="1" colspan="1" align="center">RR</th><th rowspan="1" colspan="1" align="center">RW</th><th rowspan="1" colspan="1" align="center">WW</th><th rowspan="1" colspan="1" align="center"><em>P</em><sup>||</sup></th><th rowspan="1" colspan="1" align="center">OR<sup>||</sup></th><th rowspan="1" colspan="1" align="center">95% CI</th></tr></thead><tbody valign="top"><tr><td rowspan="2" colspan="1">10</td><td rowspan="2" colspan="1" align="center">8144214</td><td rowspan="2" colspan="1" align="center">rs3824662</td><td rowspan="2" colspan="1" align="center"><strong>A</strong>/C</td><td rowspan="1" colspan="1" align="center">Discovery</td><td rowspan="1" colspan="1" align="center">35</td><td rowspan="1" colspan="1" align="center">36</td><td rowspan="1" colspan="1" align="center">145</td><td rowspan="1" colspan="1" align="center">125</td><td rowspan="1" colspan="1" align="center">20</td><td rowspan="1" colspan="1" align="center">341</td><td rowspan="1" colspan="1" align="center">2078</td><td rowspan="1" colspan="1" align="center">4242</td><td rowspan="1" colspan="1" align="center">2.84 × 10<sup>-10</sup></td><td rowspan="1" colspan="1" align="center">1.77</td><td rowspan="1" colspan="1" align="center">1.48-2.12</td></tr><tr><td rowspan="1" colspan="1" align="center">Replication</td><td rowspan="1" colspan="1" align="center">39</td><td rowspan="1" colspan="1" align="center">24</td><td rowspan="1" colspan="1" align="center">78</td><td rowspan="1" colspan="1" align="center">59</td><td rowspan="1" colspan="1" align="center">18</td><td rowspan="1" colspan="1" align="center">226</td><td rowspan="1" colspan="1" align="center">1651</td><td rowspan="1" colspan="1" align="center">3876</td><td rowspan="1" colspan="1" align="center">1.52 × 10<sup>-10</sup></td><td rowspan="1" colspan="1" align="center">2.21</td><td rowspan="1" colspan="1" align="center">1.72-2.83</td></tr><tr><td rowspan="2" colspan="1">10</td><td rowspan="2" colspan="1" align="center">8141933</td><td rowspan="2" colspan="1" align="center">rs3781093</td><td rowspan="2" colspan="1" align="center"><strong>C</strong>/T</td><td rowspan="1" colspan="1" align="center">Discovery</td><td rowspan="1" colspan="1" align="center">33</td><td rowspan="1" colspan="1" align="center">34</td><td rowspan="1" colspan="1" align="center">137</td><td rowspan="1" colspan="1" align="center">136</td><td rowspan="1" colspan="1" align="center">22</td><td rowspan="1" colspan="1" align="center">380</td><td rowspan="1" colspan="1" align="center">2254</td><td rowspan="1" colspan="1" align="center">4025</td><td rowspan="1" colspan="1" align="center">3.20 × 10<sup>-9</sup></td><td rowspan="1" colspan="1" align="center">1.73</td><td rowspan="1" colspan="1" align="center">1.44-2.08</td></tr><tr><td rowspan="1" colspan="1" align="center">Replication</td><td rowspan="1" colspan="1" align="center">35</td><td rowspan="1" colspan="1" align="center">18</td><td rowspan="1" colspan="1" align="center">75</td><td rowspan="1" colspan="1" align="center">64</td><td rowspan="1" colspan="1" align="center">18</td><td rowspan="1" colspan="1" align="center">236</td><td rowspan="1" colspan="1" align="center">1702</td><td rowspan="1" colspan="1" align="center">3809</td><td rowspan="1" colspan="1" align="center">1.00 × 10<sup>-7</sup></td><td rowspan="1" colspan="1" align="center">1.96</td><td rowspan="1" colspan="1" align="center">1.52-2.54</td></tr></tbody></table></div><div id="largeobj_idm139629876590304" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC4304112/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="idm139629798808144"><p id="__p23" class="p p-first-last">Association of SNP genotype and ALL was evaluated by comparing allele frequency between ALL and non-ALL, after adjusting for genetic ancestry.</p></div><div id="idm139629798807120"><p id="__p24" class="p p-first-last">Chr, chromosome.</p></div><div id="TF1-1"><sup>*</sup>Chromosomal locations are based on hg18.</div><div id="TF1-2"><sup>†</sup>Bold indicates risk allele for ALL.</div><div id="TF1-3"><sup>‡</sup>Genotype is denoted by RR (homozygous for the risk allele), RW (heterozygous), or WW (homozygous for the wild-type allele).</div><div id="TF1-4"><sup>§</sup>RAF, risk allele frequency (allele A at rs38246623 and allele C at rs3781093).</div><div id="TF1-5"><sup>||</sup><em>P</em> values were estimated by the logistic regression test and OR represents the increase in risk of developing ALL for each copy of the risk allele compared with participants who don’t carry the risk allele.</div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC4304112/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139629806171360" class="figure"><a href="/pmc/articles/PMC4304112/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4304112_680f2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is 680f2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC4304112/bin/680f2.jpg"></a></div><div id="largeobj_idm139629806171360" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4304112/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC4304112/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p30"><strong>Genome-wide association of SNP genotype with ALL susceptibility in AYAs.</strong> The association between genotype and ALL susceptibility was evaluated by using a logistic regression model for 635 297 SNPs in 308 AYA ALL cases and 6661 non-ALL controls. <em>P</em> values (y-axis) were plotted against respective chromosomal position of each SNP (x-axis). Points above the blue horizontal line indicate SNPs achieving the genome-wide significant threshold (<em>P</em> &lt; 5 × 10<sup>−8</sup>). Gene symbol was indicated for the <em>GATA3</em> locus at 10p14.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC4304112/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139629807782544" class="figure"><a href="/pmc/articles/PMC4304112/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4304112_680f3.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is 680f3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC4304112/bin/680f3.jpg"></a></div><div id="largeobj_idm139629807782544" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC4304112/figure/F3/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC4304112/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p31"><strong>Association of <em>GATA3</em> SNP rs3824662 with ALL in AYAs by race/ethnicity.</strong> In the discovery group (A) the A allele at rs3824662 was overrepresented in AYA ALL cases relative to non-ALL controls. This association was true within the European Americans (&gt;95% European genetic ancestry), African Americans (&gt;70% African ancestry), or Hispanic Americans (&gt;10% Native American genetic ancestry, and Native American ancestry &gt; African genetic ancestry). (B) Similar association was confirmed in the replication group (1-tailed test). Genetic ancestry was determined by using STRUCTURE (version 2.2.3) with HapMap CEU, YRI, CHB/JPT, and indigenous Native Americans as reference populations.</p></div></div></div><p id="__p32">To validate the association signals at these <em>GATA3</em> SNPs, we tested an independent set of 162 AYA ALL cases enrolled in COG P9900 and ALL0232 protocols and an additional 5,755 non-ALL controls. In the replication analysis, risk alleles at both <em>GATA3</em> SNPs were consistently overrepresented in AYA ALL cases compared with non-ALL controls: rs3824662 (OR, 2.21; 95% CI, 1.72 to 2.83; <em>P</em> = 1.52 × 10<sup>−10</sup>) and rs3781093 (OR, 1.96; 95% CI, 1.52 to 2.54; <em>P</em> = 1.0 × 10<sup>−7</sup>; <a href="/pmc/articles/PMC4304112/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>, <a href="/pmc/articles/PMC4304112/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3B</span></a>, and supplemental Figure 5B). rs3824662 was validated across race/ethnicity in the replication group (ie, EAs, 35% vs 18% [<em>P</em> = 2.0 × 10<sup>−7</sup>]; Hispanics, 55% vs 39% [<em>P</em> = .005]; and AAs, 13% vs 9% [<em>P</em> = .035]; <a href="/pmc/articles/PMC4304112/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3B</span></a>). In contrast, rs3781093 was significant in EAs and Hispanics but not in AAs (supplemental Figure 5B).</p><p id="__p33" class="p p-last">We also examined the association signals in AYAs for susceptibility loci previously identified in pediatric populations (supplemental Table 1). <em>ARID5B</em>, <em>IKZF1</em>, and <em>PIP4K2A</em> variants were nominally significant in AYAs in the discovery GWAS and/or in the replication analyses. In contrast, <em>CEBPE</em> and <em>CDKN2A/CDKN2B</em> were not associated with ALL risk in AYAs in either discovery or replication cohorts. These results imply both similarities and differences in genetic predisposition to ALL between children and AYAs.<sup><a href="#B15" rid="B15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885140">15</a></sup></p></div><div id="__sec10" class="sec"><h3 id="__sec10title"><em>GATA3</em> SNP rs3824662 and ALL subtypes in AYAs</h3><p id="__p34" class="p p-first">We further analyzed the association of the <em>GATA3</em> SNP rs3824662 with somatic ALL genomic abnormalities. Among the AYA ALL cases in the discovery cohort, the risk allele at rs3824662 was underrepresented among hyperdiploid ALL cases (22% vs 37%; <em>P</em> = .03; <a href="/pmc/articles/PMC4304112/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a> and supplemental Table 2), with a similar trend for <em>TCF3</em>-<em>PBX1</em> and <em>ETV6</em>-<em>RUNX1</em> ALL albeit not statistically significant. In contrast, the ALL risk allele frequency of rs3824662 was higher in AYA ALL cases with the Ph-like gene expression profile than in those without this signature (48% vs 32%; <em>P</em> = .02; <a href="/pmc/articles/PMC4304112/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a> and supplemental Table 2). This was consistent with our prior reports of <em>GATA3</em> as a susceptibility gene for Ph-like ALL,<sup><a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885185">36</a></sup> although there was no overlap in cases included in the current AYA ALL GWAS and those in our previous Ph-like ALL GWAS.<sup><a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885131">36</a></sup> Within Ph-like ALL, there was a trend with A allele further enriched in cases involving <em>CRLF2</em> rearrangements (<em>P</em> = .06; <a href="/pmc/articles/PMC4304112/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC4304112/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139629805504032" class="figure"><a href="/pmc/articles/PMC4304112/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4304112_680f4.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is 680f4.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC4304112/bin/680f4.jpg"></a></div><div id="largeobj_idm139629805504032" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4304112/figure/F4/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC4304112/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Figure 4</a></div><!--caption a7--><div class="caption"><p id="__p35"><strong><em>GATA3</em> SNP genotype and ALL genetic subtypes in AYAs.</strong> The allele frequency of rs3824662 varied substantially by ALL somatic genomic abnormalities, with the ALL risk allele underrepresented in hyperdiploid cases and more common in the Ph-like subtype. Numbers are based on the ALL cases included in the discovery GWAS (N = 308). The frequency of A allele at rs3824662 was 20% among unrelated non-ALL controls (MESA).</p></div></div></div><p id="__p36" class="p p-last">Importantly, even after excluding Ph-like ALL cases, the risk allele at rs3824664 was still more common in AYA ALL cases compared with non-ALL controls (rs3824662: OR, 1.56 [95% CI, 1.25 to 1.96; <em>P</em> = 8.13 × 10<sup>−5</sup>]; rs3781093: OR, 1.53 [95% CI, 1.21 to 1.92; <em>P</em> = .0002]; supplemental Figure 6). This suggested that the influence of the <em>GATA3</em> variant on ALL susceptibility in AYAs extends beyond the predisposition to Ph-like subtype.</p></div><div id="__sec11" class="sec sec-last"><h3 id="__sec11title"><em>GATA3</em> SNP rs3824662 and age at ALL diagnosis</h3><p id="__p37" class="p p-first">Finally, we examined the distribution of the <em>GATA3</em> SNP genotype by age at diagnosis in a cohort of largely unselected patients enrolled on the COG P9900 protocols (N = 1,827, age 0.1 to 21 years). When we divided patients into four consecutive age groups (&lt;5, 5 to 10, 10 to 15, and &gt;15 years), we observed a clear progressive increase in the risk allele frequency at rs3824662 (<em>P</em> = 6.29 × 10<sup>−11</sup>; <a href="/pmc/articles/PMC4304112/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5</span></a>) with increasing allelic ORs (ie, relative risk of ALL conferred by each copy of the A allele at rs3824662; <a href="/pmc/articles/PMC4304112/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5</span></a>, inset plot): 0.96 (95% CI, 0.85 to 1.09), 1.26 (95% CI, 1.08 to 1.48), 1.48 (95% CI, 1.19 to 1.84), and 2.40 (95% CI, 1.81 to 3.19). Similar correlation between <em>GATA3</em> genotype frequency and age was evident irrespective of genetic ancestry, but the <em>GATA3</em> risk allele was markedly more common in Hispanics (ie, individuals with high NA genetic ancestry; <a href="/pmc/articles/PMC4304112/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5</span></a>). To examine whether the association with age is confounded by ALL genetic subtype, we compared rs3824662 allele frequency by age in the COG P9900 protocols after stratifying ALL cases into <em>TCF3-PBX1</em>, <em>ETV6-RUNX1</em>, high hyperdiploid, <em>MLL-</em>rearranged, and B-other. There was a trend for the risk allele at this SNP to be more frequent in patients older than age 16 years relative to those younger than age 16 years in 5 subtypes examined, although with a limited sample size (supplemental Figure 7). This suggests that <em>GATA3</em> germline variants confer a general ALL disease risk in AYAs. In contrast, the frequency of ALL risk variant in <em>ARID5B</em> (rs10821936) decreased progressively with increasing age at diagnosis in the COG P9900 cohort (<em>P</em> = .006), whereas <em>PIP4K2A</em>, <em>CDKN2A/2B</em>, <em>IKZF1</em>, and <em>CEBPE</em> variants were not related to age (<em>P</em> &gt; .05; data not shown).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F5" co-legend-rid="lgnd_F5"><a href="/pmc/articles/PMC4304112/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139629805812544" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is 680f5.jpg" title="An external file that holds a picture, illustration, etc.
Object name is 680f5.jpg" src="/pmc/articles/PMC4304112/bin/680f5.jpg"></div></a><div id="largeobj_idm139629805812544" class="largeobj-link align_right" style="display: none"><a href="/pmc/articles/PMC4304112/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"></a><a target="object" href="/pmc/articles/PMC4304112/figure/F5/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F5"><div><a class="figpopup" href="/pmc/articles/PMC4304112/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5">Figure 5</a></div><!--caption a7--><div class="caption"><p id="__p38"><strong><em>GATA3</em> SNP rs3824662 and age at ALL diagnosis.</strong> In a largely unselected cohort of ALL cases enrolled on the Children’s Oncology Group (COG) P9900 trials (N = 1,827), the frequency of ALL risk allele at rs3824662 was positively correlated with patient age at diagnosis consistently across race/ethnicity. Inset figure: the relative risk of ALL (odds ratio) conferred by each copy of the A allele at rs3824662 increased progressively with age, as estimated by logistic regression after adjusting for genetic ancestry. Horizontal dotted line is odds ratio of 1. Unrelated participants from the Multi-ethnic Study of Atherosclerosis (MESA) were considered as non-ALL controls.</p></div></div></div></div></div><div id="__sec12" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec12title">Discussion</h2><p id="__p39" class="p p-first">Because ALL is the most common cancer in children, previous susceptibility GWAS studies understandably focused on pediatric populations. We hypothesized that ALL in AYAs has distinct tumor biology and genetic etiology, which potentially contribute to the disparities in treatment outcomes by age. To this end, we performed the first GWAS of ALL susceptibility specifically in the AYA population and identified a single genome-wide significant risk locus within the <em>GATA3</em> gene on 10p14.</p><p id="__p40">The susceptibility to ALL varies substantially by age. ALL risk first peaks between 2 and 5 years after birth, followed by gradual decrease into adulthood, but rises again in older individuals (older than age 70 years), suggesting that differential combinations of environmental and genetic factors contribute to leukemogenesis at different ages. For example, it has been hypothesized that infection (and supposedly acquired immunity) may ameliorate susceptibility to ALL in young children,<sup><a href="#B41" rid="B41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885167">41</a>,<a href="#B42" rid="B42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885190">42</a></sup> which may not be important in ALL that occurs later in life. Similarly, the in utero occurrence of genomic lesions is characteristic in many (if not most) pediatric ALL cases,<sup><a href="#B43" rid="B43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885156">43</a>,<a href="#B44" rid="B44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885189">44</a></sup> whereas such early origin of presumed initiating events may not be evident in AYAs ALL. Age-dependent differences in lymphocyte development and function are well documented in human and mouse systems,<sup><a href="#B45" rid="B45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885148">45</a></sup> and rapid growth of hematopoietic cells may render them particularly susceptible to oncogenic assaults.<sup><a href="#B46" rid="B46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885187">46</a></sup> Thus, it can be postulated that specific ALL susceptibility genes are required during a particular stage of hematopoietic development and preferentially influence ALL risk within a certain age range. For example, loss of <em>Arid5b</em> in mice resulted in reduction of lymphoid cells in bone marrow within 3 weeks after birth, but the effect became blunted by 6 weeks.<sup><a href="#B47" rid="B47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885169">47</a></sup> In fact, germline <em>ARID5B</em> variants also exhibited increasing influence on ALL predisposition in children as age decreases.<sup><a href="#B15" rid="B15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885145">15</a></sup></p><p id="__p41"><em>GATA3</em> encodes for a transcription factor critical for lymphoid cell lineage commitment and early T-cell differentiation,<sup><a href="#B48" rid="B48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885181">48</a></sup> and loss-of-function somatic mutations have been discovered in early T-cell precursor ALL.<sup><a href="#B49" rid="B49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885192">49</a></sup> Germline polymorphisms in <em>GATA3</em>, however, appear more important for B-cell malignancies.<sup><a href="#B50" rid="B50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885146">50</a></sup> We recently reported that rs3824662 was significantly associated with susceptibility to Ph-like ALL in children and risk of relapse.<sup><a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885136">36</a></sup> A contemporaneous study by Migliorini et al<sup><a href="#B17" rid="B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885129">17</a></sup> reported the same ALL susceptibility variant in <em>GATA3</em> in children of European descent and associated it with relapse. Particularly of note, <em>GATA3</em> risk variants also appeared enriched in older children, even within their predominantly pediatric cohort. The association of rs3824662 with ALL relapse<sup><a href="#B17" rid="B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885176">17</a>,<a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885173">36</a></sup> is in line with the negative prognosis by age and higher frequency of the <em>GATA3</em> variant in AYAs with ALL. Nevertheless, it is unclear whether poor prognosis conferred by a <em>GATA3</em> variant was driven by its association with a high-risk subtype (ie, Ph-like ALL), novel somatic genomic aberrations specific to AYA, and/or host biology related to antileukemic drug response. Interestingly, in AYA cases included in the discovery GWAS, the number of the risk allele at rs3824662 was significantly associated with <em>GATA3</em> expression in ALL blasts (<em>P</em> = .02; supplemental Figure 8), consistent with our previous report in pediatric ALL cases of this variant functioning as a <em>cis</em>-acting regulatory element of <em>GATA3</em> transcription.<sup><a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885139">36</a></sup></p><p id="__p42">The overrepresentation of the <em>GATA3</em> variant in AYAs is consistent with its association with Ph-like ALL<sup><a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885161">36</a></sup> for which the frequency increases with age.<sup><a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_422885193">8</a></sup> However, the risk variant at rs3824662 remained significantly associated with susceptibility to AYA ALL cases without Ph-like expression pattern, suggesting the link to Ph-like ALL contributed only partly to the genome-wide significant association signal at rs3824662. In fact, the <em>GATA3</em> risk allele tended to be more common in ALL patients age 16 years or older than in those age younger than 16 years consistently across different genetic subtypes, plausibly conferring a general ALL risk in AYAs. It remains unknown how the <em>GATA3</em> variants influence the risk of developing ALL in older adults, including the elderly (&gt;60 years). Future studies including this age group may provide insights on molecular etiology of ALL across the age spectrum. It is also noteworthy that <em>MLL</em>-rearranged cases had the second highest <em>GATA3</em> risk variant frequency (<a href="/pmc/articles/PMC4304112/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a>), although the number of patients was relatively small and the difference did not reach statistical significance. Future studies are warranted to comprehensively characterize potential interactions of germline <em>GATA3</em> variants with somatic genomic lesions in ALL.</p><p id="__p43" class="p p-last">In conclusion, our GWAS identified inherited <em>GATA3</em> genetic variants that strongly influence ALL susceptibility in adolescents and young adults, shedding new light on potential age-related differences in ALL biology and treatment outcome.</p></div><div id="idm139629799710848" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139629799710848title">Acknowledgments</h2><div class="sec"><p id="__p46">The authors thank the patients and parents who participated in the clinical trials included in this study and M. Shriver (Pennsylvania State University) for sharing SNP genotype data for the Native American references. Genome-wide genotyping of COG P9904/P9905 samples was performed by the Center for Molecular Medicine with the generous financial support from the Jeffrey Pride Foundation and the National Childhood Cancer Foundation.</p><p id="__p47">This work was supported by the National Institutes of Health, National Cancer Institute grants CA145707, <a id="__tag_779930767" class="tag_hotlink" href="/nuccore/CA156449" ref="/nuccore/CA156449"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"CA156449","term_id":"35065706","term_text":"CA156449"}}</span>CA156449</a>, CA21765, CA36401, CA98543, <a id="__tag_779930765" class="tag_hotlink" href="/nuccore/CA114766" ref="/nuccore/CA114766"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"CA114766","term_id":"34968073","term_text":"CA114766"}}</span>CA114766</a>, CA98413, <a id="__tag_779930764" class="tag_hotlink" href="/nuccore/CA140729" ref="/nuccore/CA140729"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"CA140729","term_id":"35034007","term_text":"CA140729"}}</span>CA140729</a>, <a id="__tag_779930766" class="tag_hotlink" href="/nuccore/CA176063" ref="/nuccore/CA176063"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"CA176063","term_id":"35105415","term_text":"CA176063"}}</span>CA176063</a>, and HHSN261200800001E, the National Institute of General Medical Sciences grant GM92666, in part by the intramural Program of the National Cancer Institute, by a Stand Up to Cancer Innovative Research Grant, and by the American Lebanese Syrian Associated Charities of St. Jude Children’s Research Hospital, by a St. Jude Children’s Research Hospital Academic Programs Special Fellowship and a Spanish Ministry of Education Fellowship Grant (V.P.-A.), by the American Society of Hematology Scholar Award and by the Order of St. Francis Foundation (J.J.Y.), and by a Leukemia and Lymphoma Society Fellow Award and Alex’s Lemonade Stand Foundation Young Investigator Award (K.G.R.). S.P.H. is the Ergen Family Chair in Pediatric Cancer, C.G.M. is a Pew Scholar in the Biomedical Sciences and a St. Baldrick’s Scholar, and H.Z. is a St. Baldrick’s International Scholar.</p><p id="__p48">The study sponsors were not directly involved in the design of the study, the collection, analysis, and interpretation of the data, the writing of the manuscript, or the decision to submit the manuscript.</p></div></div><div id="idm139629805666160" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139629805666160title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm139629805666032"></p><p id="__p44" class="p p-first-last">The online version of this article contains a data supplement.</p><p></p><p class="fn sec" id="idm139629805665040"></p><p id="__p45" class="p p-first-last">The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked “advertisement” in accordance with 18 USC section 1734.</p><p></p></div></div><div id="__sec13" class="tsec bk-sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec13title">Authorship</h2><!--/article/back/sec/--><p id="__p49" class="p p-first">Contribution: V.P.-A., K.G.R., H.X., C.G.M., and J.J.Y. conceived of and designed the study; R.C.H., D.P.-T., I-M.C., W.L.C., N.A.H., A.J.C., E.A.R., J.M.G.-F., G.M., C.D.B., K.M., J.K., W.S., S.M.K., M.K., E.P., J.M.R., S.M.L., M.S.T., M.D., E.G.B., D.G.T., F.Y., Y.W., C.-H.P., S.J., M.V.R., W.E.E., D.S.G., M.L.L., S.P.H., and C.L.W. provided study materials or patients; V.P.-A., K.G.R., H.X., M.D., I-M.C., C.L.W., R.C.H., M.V.R., and W.E.E. collected and assembled data; V.P.-A., H.X., C.S., W.Y., H.Z., M.D., R.C.H., I-M.C., and J.J.Y. analyzed and interpreted data; V.P.-A., H.X., C.G.M., and J.J.Y. wrote the manuscript; and all authors gave final approval for the manuscript.</p><p id="__p50">Conflict-of-interest disclosure: The authors declare no competing financial interests.</p><p id="__p51" class="p p-last">Correspondence: Jun J. Yang, Department of Pharmaceutical Sciences, MS 313, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105-3678; e-mail: <a href="mailto:dev@null" data-email="gro.edujts@gnay.nuj" class="oemail">gro.edujts@gnay.nuj</a>; and Charles G. Mullighan, Department of Pathology, MS 342, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105-3678; e-mail:<a href="mailto:dev@null" data-email="gro.edujts@nahgillum.selrahc" class="oemail">gro.edujts@nahgillum.selrahc</a>.</p></div><div id="idm139629797366192" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139629797366192title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="B1">1. <span class="element-citation">Lukenbill J, Advani AS. The treatment of adolescents and young adults with acute lymphoblastic leukemia. <span><span class="ref-journal">Curr Hematol Malig Rep. </span>2013;<span class="ref-vol">8</span>(2):91–97.</span> [<a href="/pubmed/23559026" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Hematol+Malig+Rep&amp;title=The+treatment+of+adolescents+and+young+adults+with+acute+lymphoblastic+leukemia.&amp;author=J+Lukenbill&amp;author=AS+Advani&amp;volume=8&amp;issue=2&amp;publication_year=2013&amp;pages=91-97&amp;pmid=23559026&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B2">2. <span class="element-citation">Place AE, Frederick NN, Sallan SE. Therapeutic approaches to haematological malignancies in adolescents and young adults. <span><span class="ref-journal">Br J Haematol. </span>2014;<span class="ref-vol">164</span>(1):3–14.</span> [<a href="/pubmed/24007213" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Haematol&amp;title=Therapeutic+approaches+to+haematological+malignancies+in+adolescents+and+young+adults.&amp;author=AE+Place&amp;author=NN+Frederick&amp;author=SE+Sallan&amp;volume=164&amp;issue=1&amp;publication_year=2014&amp;pages=3-14&amp;pmid=24007213&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B3">3. <span class="element-citation">Hunger SP, Lu X, Devidas M, et al.  Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group. <span><span class="ref-journal">J Clin Oncol. </span>2012;<span class="ref-vol">30</span>(14):1663–1669.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3383113/">PMC free article</a>]</span> [<a href="/pubmed/22412151" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Improved+survival+for+children+and+adolescents+with+acute+lymphoblastic+leukemia+between+1990+and+2005:+a+report+from+the+children’s+oncology+group.&amp;author=SP+Hunger&amp;author=X+Lu&amp;author=M+Devidas&amp;volume=30&amp;issue=14&amp;publication_year=2012&amp;pages=1663-1669&amp;pmid=22412151&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B4">4. <span class="element-citation">Ram R, Wolach O, Vidal L, Gafter-Gvili A, Shpilberg O, Raanani P. Adolescents and young adults with acute lymphoblastic leukemia have a better outcome when treated with pediatric-inspired regimens: systematic review and meta-analysis. <span><span class="ref-journal">Am J Hematol. </span>2012;<span class="ref-vol">87</span>(5):472–478.</span> [<a href="/pubmed/22388572" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hematol&amp;title=Adolescents+and+young+adults+with+acute+lymphoblastic+leukemia+have+a+better+outcome+when+treated+with+pediatric-inspired+regimens:+systematic+review+and+meta-analysis.&amp;author=R+Ram&amp;author=O+Wolach&amp;author=L+Vidal&amp;author=A+Gafter-Gvili&amp;author=O+Shpilberg&amp;volume=87&amp;issue=5&amp;publication_year=2012&amp;pages=472-478&amp;pmid=22388572&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B5">5. <span class="element-citation">Schafer ES, Hunger SP. Optimal therapy for acute lymphoblastic leukemia in adolescents and young adults. <span><span class="ref-journal">Nat Rev Clin Oncol. </span>2011;<span class="ref-vol">8</span>(7):417–424.</span> [<a href="/pubmed/21629213" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Clin+Oncol&amp;title=Optimal+therapy+for+acute+lymphoblastic+leukemia+in+adolescents+and+young+adults.&amp;author=ES+Schafer&amp;author=SP+Hunger&amp;volume=8&amp;issue=7&amp;publication_year=2011&amp;pages=417-424&amp;pmid=21629213&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B6">6. <span class="element-citation">Gramatges MM, Rabin KR. The adolescent and young adult with cancer: state of the art— acute leukemias. <span><span class="ref-journal">Curr Oncol Rep. </span>2013;<span class="ref-vol">15</span>(4):317–324.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3758222/">PMC free article</a>]</span> [<a href="/pubmed/23757222" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Oncol+Rep&amp;title=The+adolescent+and+young+adult+with+cancer:+state+of+the+art—+acute+leukemias.&amp;author=MM+Gramatges&amp;author=KR+Rabin&amp;volume=15&amp;issue=4&amp;publication_year=2013&amp;pages=317-324&amp;pmid=23757222&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B7">7. <span class="element-citation">Aricò M, Schrappe M, Hunger SP, et al.  Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005. <span><span class="ref-journal">J Clin Oncol. </span>2010;<span class="ref-vol">28</span>(31):4755–4761.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3020705/">PMC free article</a>]</span> [<a href="/pubmed/20876426" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Clinical+outcome+of+children+with+newly+diagnosed+Philadelphia+chromosome-positive+acute+lymphoblastic+leukemia+treated+between+1995+and+2005.&amp;author=M+Aricò&amp;author=M+Schrappe&amp;author=SP+Hunger&amp;volume=28&amp;issue=31&amp;publication_year=2010&amp;pages=4755-4761&amp;pmid=20876426&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B8">8. <span class="element-citation">Roberts KG, Li Y, Payne-Turner D, et al.  Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. <span><span class="ref-journal">N Engl J Med. </span>2014;<span class="ref-vol">371</span>(11):1005–1015.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4191900/">PMC free article</a>]</span> [<a href="/pubmed/25207766" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Targetable+kinase-activating+lesions+in+Ph-like+acute+lymphoblastic+leukemia.&amp;author=KG+Roberts&amp;author=Y+Li&amp;author=D+Payne-Turner&amp;volume=371&amp;issue=11&amp;publication_year=2014&amp;pages=1005-1015&amp;pmid=25207766&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B9">9. <span class="element-citation">Harrison CJ. Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia. <span><span class="ref-journal">Br J Haematol. </span>2009;<span class="ref-vol">144</span>(2):147–156.</span> [<a href="/pubmed/19006567" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Haematol&amp;title=Cytogenetics+of+paediatric+and+adolescent+acute+lymphoblastic+leukaemia.&amp;author=CJ+Harrison&amp;volume=144&amp;issue=2&amp;publication_year=2009&amp;pages=147-156&amp;pmid=19006567&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B10">10. <span class="element-citation">Chessells JM, Hall E, Prentice HG, Durrant J, Bailey CC, Richards SM. The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties. <span><span class="ref-journal">Leukemia. </span>1998;<span class="ref-vol">12</span>(4):463–473.</span> [<a href="/pubmed/9557602" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=The+impact+of+age+on+outcome+in+lymphoblastic+leukaemia;+MRC+UKALL+X+and+XA+compared:+a+report+from+the+MRC+Paediatric+and+Adult+Working+Parties.&amp;author=JM+Chessells&amp;author=E+Hall&amp;author=HG+Prentice&amp;author=J+Durrant&amp;author=CC+Bailey&amp;volume=12&amp;issue=4&amp;publication_year=1998&amp;pages=463-473&amp;pmid=9557602&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B11">11. <span class="element-citation">Rubnitz JE, Wichlan D, Devidas M, et al.  Children’s Oncology Group. Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children’s Oncology Group study. <span><span class="ref-journal">J Clin Oncol. </span>2008;<span class="ref-vol">26</span>(13):2186–2191.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4485397/">PMC free article</a>]</span> [<a href="/pubmed/18445843" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Prospective+analysis+of+TEL+gene+rearrangements+in+childhood+acute+lymphoblastic+leukemia:+a+Children’s+Oncology+Group+study.&amp;author=JE+Rubnitz&amp;author=D+Wichlan&amp;author=M+Devidas&amp;volume=26&amp;issue=13&amp;publication_year=2008&amp;pages=2186-2191&amp;pmid=18445843&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B12">12. <span class="element-citation">Papaemmanuil E, Hosking FJ, Vijayakrishnan J, et al.  Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. <span><span class="ref-journal">Nat Genet. </span>2009;<span class="ref-vol">41</span>(9):1006–1010.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4915548/">PMC free article</a>]</span> [<a href="/pubmed/19684604" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Loci+on+7p12.2,+10q21.2+and+14q11.2+are+associated+with+risk+of+childhood+acute+lymphoblastic+leukemia.&amp;author=E+Papaemmanuil&amp;author=FJ+Hosking&amp;author=J+Vijayakrishnan&amp;volume=41&amp;issue=9&amp;publication_year=2009&amp;pages=1006-1010&amp;pmid=19684604&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B13">13. <span class="element-citation">Sherborne AL, Hosking FJ, Prasad RB, et al.  Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. <span><span class="ref-journal">Nat Genet. </span>2010;<span class="ref-vol">42</span>(6):492–494.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3434228/">PMC free article</a>]</span> [<a href="/pubmed/20453839" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Variation+in+CDKN2A+at+9p21.3+influences+childhood+acute+lymphoblastic+leukemia+risk.&amp;author=AL+Sherborne&amp;author=FJ+Hosking&amp;author=RB+Prasad&amp;volume=42&amp;issue=6&amp;publication_year=2010&amp;pages=492-494&amp;pmid=20453839&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B14">14. <span class="element-citation">Treviño LR, Yang W, French D, et al.  Germline genomic variants associated with childhood acute lymphoblastic leukemia. <span><span class="ref-journal">Nat Genet. </span>2009;<span class="ref-vol">41</span>(9):1001–1005.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2762391/">PMC free article</a>]</span> [<a href="/pubmed/19684603" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Germline+genomic+variants+associated+with+childhood+acute+lymphoblastic+leukemia.&amp;author=LR+Treviño&amp;author=W+Yang&amp;author=D+French&amp;volume=41&amp;issue=9&amp;publication_year=2009&amp;pages=1001-1005&amp;pmid=19684603&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B15">15. <span class="element-citation">Xu H, Yang W, Perez-Andreu V, et al.  Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. <span><span class="ref-journal">J Natl Cancer Inst. </span>2013;<span class="ref-vol">105</span>(10):733–742.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3691938/">PMC free article</a>]</span> [<a href="/pubmed/23512250" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Natl+Cancer+Inst&amp;title=Novel+susceptibility+variants+at+10p12.31-12.2+for+childhood+acute+lymphoblastic+leukemia+in+ethnically+diverse+populations.&amp;author=H+Xu&amp;author=W+Yang&amp;author=V+Perez-Andreu&amp;volume=105&amp;issue=10&amp;publication_year=2013&amp;pages=733-742&amp;pmid=23512250&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B16">16. <span class="element-citation">Xu H, Cheng C, Devidas M, et al.  ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. <span><span class="ref-journal">J Clin Oncol. </span>2012;<span class="ref-vol">30</span>(7):751–757.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3295551/">PMC free article</a>]</span> [<a href="/pubmed/22291082" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=ARID5B+genetic+polymorphisms+contribute+to+racial+disparities+in+the+incidence+and+treatment+outcome+of+childhood+acute+lymphoblastic+leukemia.&amp;author=H+Xu&amp;author=C+Cheng&amp;author=M+Devidas&amp;volume=30&amp;issue=7&amp;publication_year=2012&amp;pages=751-757&amp;pmid=22291082&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B17">17. <span class="element-citation">Migliorini G, Fiege B, Hosking FJ, et al.  Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype. <span><span class="ref-journal">Blood. </span>2013;<span class="ref-vol">122</span>(19):3298–3307.</span> [<a href="/pubmed/23996088" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Variation+at+10p12.2+and+10p14+influences+risk+of+childhood+B-cell+acute+lymphoblastic+leukemia+and+phenotype.&amp;author=G+Migliorini&amp;author=B+Fiege&amp;author=FJ+Hosking&amp;volume=122&amp;issue=19&amp;publication_year=2013&amp;pages=3298-3307&amp;pmid=23996088&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B18">18. <span class="element-citation">Yang JJ, Cheng C, Devidas M, et al.  Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia. <span><span class="ref-journal">Blood. </span>2012;<span class="ref-vol">120</span>(20):4197–4204.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3501717/">PMC free article</a>]</span> [<a href="/pubmed/23007406" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Genome-wide+association+study+identifies+germline+polymorphisms+associated+with+relapse+of+childhood+acute+lymphoblastic+leukemia.&amp;author=JJ+Yang&amp;author=C+Cheng&amp;author=M+Devidas&amp;volume=120&amp;issue=20&amp;publication_year=2012&amp;pages=4197-4204&amp;pmid=23007406&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B19">19. <span class="element-citation">Yang JJ, Cheng C, Yang W, et al.  Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. <span><span class="ref-journal">JAMA. </span>2009;<span class="ref-vol">301</span>(4):393–403.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2664534/">PMC free article</a>]</span> [<a href="/pubmed/19176441" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Genome-wide+interrogation+of+germline+genetic+variation+associated+with+treatment+response+in+childhood+acute+lymphoblastic+leukemia.&amp;author=JJ+Yang&amp;author=C+Cheng&amp;author=W+Yang&amp;volume=301&amp;issue=4&amp;publication_year=2009&amp;pages=393-403&amp;pmid=19176441&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B20">20. <span class="element-citation">Yang JJ, Cheng C, Devidas M, et al.  Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia. <span><span class="ref-journal">Nat Genet. </span>2011;<span class="ref-vol">43</span>(3):237–241.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3104508/">PMC free article</a>]</span> [<a href="/pubmed/21297632" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Ancestry+and+pharmacogenomics+of+relapse+in+acute+lymphoblastic+leukemia.&amp;author=JJ+Yang&amp;author=C+Cheng&amp;author=M+Devidas&amp;volume=43&amp;issue=3&amp;publication_year=2011&amp;pages=237-241&amp;pmid=21297632&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B21">21. <span class="element-citation">Roberts KG, Morin RD, Zhang J, et al.  Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. <span><span class="ref-journal">Cancer Cell. </span>2012;<span class="ref-vol">22</span>(2):153–166.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3422513/">PMC free article</a>]</span> [<a href="/pubmed/22897847" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Cell&amp;title=Genetic+alterations+activating+kinase+and+cytokine+receptor+signaling+in+high-risk+acute+lymphoblastic+leukemia.&amp;author=KG+Roberts&amp;author=RD+Morin&amp;author=J+Zhang&amp;volume=22&amp;issue=2&amp;publication_year=2012&amp;pages=153-166&amp;pmid=22897847&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B22">22. <span class="element-citation">Stock W, La M, Sanford B, et al.  Children’s Cancer Group; Cancer and Leukemia Group B studies. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children’s Cancer Group and Cancer and Leukemia Group B studies. <span><span class="ref-journal">Blood. </span>2008;<span class="ref-vol">112</span>(5):1646–1654.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2518876/">PMC free article</a>]</span> [<a href="/pubmed/18502832" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=What+determines+the+outcomes+for+adolescents+and+young+adults+with+acute+lymphoblastic+leukemia+treated+on+cooperative+group+protocols?+A+comparison+of+Children’s+Cancer+Group+and+Cancer+and+Leukemia+Group+B+studies.&amp;author=W+Stock&amp;author=M+La&amp;author=B+Sanford&amp;volume=112&amp;issue=5&amp;publication_year=2008&amp;pages=1646-1654&amp;pmid=18502832&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B23">23. <span class="element-citation">Lazarus HM, Richards SM, Chopra R, et al.  Medical Research Council (MRC)/National Cancer Research Institute (NCRI) Adult Leukaemia Working Party of the United Kingdom and the Eastern Cooperative Oncology Group. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993. <span><span class="ref-journal">Blood. </span>2006;<span class="ref-vol">108</span>(2):465–472.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1895498/">PMC free article</a>]</span> [<a href="/pubmed/16556888" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Central+nervous+system+involvement+in+adult+acute+lymphoblastic+leukemia+at+diagnosis:+results+from+the+international+ALL+trial+MRC+UKALL+XII/ECOG+E2993.&amp;author=HM+Lazarus&amp;author=SM+Richards&amp;author=R+Chopra&amp;volume=108&amp;issue=2&amp;publication_year=2006&amp;pages=465-472&amp;pmid=16556888&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B24">24. <span class="element-citation">Kantarjian H, Thomas D, O’Brien S, et al.  Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. <span><span class="ref-journal">Cancer. </span>2004;<span class="ref-vol">101</span>(12):2788–2801.</span> [<a href="/pubmed/15481055" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Long-term+follow-up+results+of+hyperfractionated+cyclophosphamide,+vincristine,+doxorubicin,+and+dexamethasone+(Hyper-CVAD),+a+dose-intensive+regimen,+in+adult+acute+lymphocytic+leukemia.&amp;author=H+Kantarjian&amp;author=D+Thomas&amp;author=S+O’Brien&amp;volume=101&amp;issue=12&amp;publication_year=2004&amp;pages=2788-2801&amp;pmid=15481055&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B25">25. <span class="element-citation">Ravandi F, O’Brien S, Thomas D, et al.  First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia. <span><span class="ref-journal">Blood. </span>2010;<span class="ref-vol">116</span>(12):2070–2077.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4081177/">PMC free article</a>]</span> [<a href="/pubmed/20466853" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=First+report+of+phase+2+study+of+dasatinib+with+hyper-CVAD+for+the+frontline+treatment+of+patients+with+Philadelphia+chromosome-positive+(Ph+)+acute+lymphoblastic+leukemia.&amp;author=F+Ravandi&amp;author=S+O’Brien&amp;author=D+Thomas&amp;volume=116&amp;issue=12&amp;publication_year=2010&amp;pages=2070-2077&amp;pmid=20466853&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B26">26. <span class="element-citation">Thomas DA, Faderl S, Cortes J, et al.  Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate. <span><span class="ref-journal">Blood. </span>2004;<span class="ref-vol">103</span>(12):4396–4407.</span> [<a href="/pubmed/14551133" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Treatment+of+Philadelphia+chromosome-positive+acute+lymphocytic+leukemia+with+hyper-CVAD+and+imatinib+mesylate.&amp;author=DA+Thomas&amp;author=S+Faderl&amp;author=J+Cortes&amp;volume=103&amp;issue=12&amp;publication_year=2004&amp;pages=4396-4407&amp;pmid=14551133&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B27">27. <span class="element-citation">Thomas DA, O’Brien S, Faderl S, et al.  Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia. <span><span class="ref-journal">J Clin Oncol. </span>2010;<span class="ref-vol">28</span>(24):3880–3889.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2940403/">PMC free article</a>]</span> [<a href="/pubmed/20660823" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Chemoimmunotherapy+with+a+modified+hyper-CVAD+and+rituximab+regimen+improves+outcome+in+de+novo+Philadelphia+chromosome-negative+precursor+B-lineage+acute+lymphoblastic+leukemia.&amp;author=DA+Thomas&amp;author=S+O’Brien&amp;author=S+Faderl&amp;volume=28&amp;issue=24&amp;publication_year=2010&amp;pages=3880-3889&amp;pmid=20660823&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B28">28. <span class="element-citation">Pui CH, Campana D, Pei D, et al.  Treating childhood acute lymphoblastic leukemia without cranial irradiation. <span><span class="ref-journal">N Engl J Med. </span>2009;<span class="ref-vol">360</span>(26):2730–2741.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2754320/">PMC free article</a>]</span> [<a href="/pubmed/19553647" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Treating+childhood+acute+lymphoblastic+leukemia+without+cranial+irradiation.&amp;author=CH+Pui&amp;author=D+Campana&amp;author=D+Pei&amp;volume=360&amp;issue=26&amp;publication_year=2009&amp;pages=2730-2741&amp;pmid=19553647&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B29">29. <span class="element-citation">Borowitz MJ, Devidas M, Hunger SP, et al.  Children’s Oncology Group. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children’s Oncology Group study. <span><span class="ref-journal">Blood. </span>2008;<span class="ref-vol">111</span>(12):5477–5485.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2424148/">PMC free article</a>]</span> [<a href="/pubmed/18388178" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Clinical+significance+of+minimal+residual+disease+in+childhood+acute+lymphoblastic+leukemia+and+its+relationship+to+other+prognostic+factors:+a+Children’s+Oncology+Group+study.&amp;author=MJ+Borowitz&amp;author=M+Devidas&amp;author=SP+Hunger&amp;volume=111&amp;issue=12&amp;publication_year=2008&amp;pages=5477-5485&amp;pmid=18388178&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B30">30. <span class="element-citation">Harvey RC, Mullighan CG, Chen IM, et al.  Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. <span><span class="ref-journal">Blood. </span>2010;<span class="ref-vol">115</span>(26):5312–5321.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2902132/">PMC free article</a>]</span> [<a href="/pubmed/20139093" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Rearrangement+of+CRLF2+is+associated+with+mutation+of+JAK+kinases,+alteration+of+IKZF1,+Hispanic/Latino+ethnicity,+and+a+poor+outcome+in+pediatric+B-progenitor+acute+lymphoblastic+leukemia.&amp;author=RC+Harvey&amp;author=CG+Mullighan&amp;author=IM+Chen&amp;volume=115&amp;issue=26&amp;publication_year=2010&amp;pages=5312-5321&amp;pmid=20139093&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B31">31. <span class="element-citation">Troyer JL, Nelson GW, Lautenberger JA, et al.  Genome-wide association study implicates PARD3B-based AIDS restriction. <span><span class="ref-journal">J Infect Dis. </span>2011;<span class="ref-vol">203</span>(10):1491–1502.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3080910/">PMC free article</a>]</span> [<a href="/pubmed/21502085" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Genome-wide+association+study+implicates+PARD3B-based+AIDS+restriction.&amp;author=JL+Troyer&amp;author=GW+Nelson&amp;author=JA+Lautenberger&amp;volume=203&amp;issue=10&amp;publication_year=2011&amp;pages=1491-1502&amp;pmid=21502085&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B32">32. <span class="element-citation">Burchard EG, Avila PC, Nazario S, et al.  Genetics of Asthma in Latino Americans (GALA) Study. Lower bronchodilator responsiveness in Puerto Rican than in Mexican subjects with asthma. <span><span class="ref-journal">Am J Respir Crit Care Med. </span>2004;<span class="ref-vol">169</span>(3):386–392.</span> [<a href="/pubmed/14617512" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&amp;title=Lower+bronchodilator+responsiveness+in+Puerto+Rican+than+in+Mexican+subjects+with+asthma.&amp;author=EG+Burchard&amp;author=PC+Avila&amp;author=S+Nazario&amp;volume=169&amp;issue=3&amp;publication_year=2004&amp;pages=386-392&amp;pmid=14617512&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B33">33. <span class="element-citation">Shi J, Levinson DF, Duan J, et al.  Common variants on chromosome 6p22.1 are associated with schizophrenia. <span><span class="ref-journal">Nature. </span>2009;<span class="ref-vol">460</span>(7256):753–757.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2775422/">PMC free article</a>]</span> [<a href="/pubmed/19571809" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Common+variants+on+chromosome+6p22.1+are+associated+with+schizophrenia.&amp;author=J+Shi&amp;author=DF+Levinson&amp;author=J+Duan&amp;volume=460&amp;issue=7256&amp;publication_year=2009&amp;pages=753-757&amp;pmid=19571809&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B34">34. <span class="element-citation">Purcell SM, Wray NR, Stone JL, et al.  International Schizophrenia Consortium. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. <span><span class="ref-journal">Nature. </span>2009;<span class="ref-vol">460</span>(7256):748–752.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3912837/">PMC free article</a>]</span> [<a href="/pubmed/19571811" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Common+polygenic+variation+contributes+to+risk+of+schizophrenia+and+bipolar+disorder.&amp;author=SM+Purcell&amp;author=NR+Wray&amp;author=JL+Stone&amp;volume=460&amp;issue=7256&amp;publication_year=2009&amp;pages=748-752&amp;pmid=19571811&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B35">35. <span class="element-citation">Korn JM, Kuruvilla FG, McCarroll SA, et al.  Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. <span><span class="ref-journal">Nat Genet. </span>2008;<span class="ref-vol">40</span>(10):1253–1260.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2756534/">PMC free article</a>]</span> [<a href="/pubmed/18776909" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Integrated+genotype+calling+and+association+analysis+of+SNPs,+common+copy+number+polymorphisms+and+rare+CNVs.&amp;author=JM+Korn&amp;author=FG+Kuruvilla&amp;author=SA+McCarroll&amp;volume=40&amp;issue=10&amp;publication_year=2008&amp;pages=1253-1260&amp;pmid=18776909&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B36">36. <span class="element-citation">Perez-Andreu V, Roberts KG, Harvey RC, et al.  Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse. <span><span class="ref-journal">Nat Genet. </span>2013;<span class="ref-vol">45</span>(12):1494–1498.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4039076/">PMC free article</a>]</span> [<a href="/pubmed/24141364" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Inherited+GATA3+variants+are+associated+with+Ph-like+childhood+acute+lymphoblastic+leukemia+and+risk+of+relapse.&amp;author=V+Perez-Andreu&amp;author=KG+Roberts&amp;author=RC+Harvey&amp;volume=45&amp;issue=12&amp;publication_year=2013&amp;pages=1494-1498&amp;pmid=24141364&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B37">37. <span class="element-citation">Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. <span><span class="ref-journal">Genetics. </span>2000;<span class="ref-vol">155</span>(2):945–959.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1461096/">PMC free article</a>]</span> [<a href="/pubmed/10835412" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genetics&amp;title=Inference+of+population+structure+using+multilocus+genotype+data.&amp;author=JK+Pritchard&amp;author=M+Stephens&amp;author=P+Donnelly&amp;volume=155&amp;issue=2&amp;publication_year=2000&amp;pages=945-959&amp;pmid=10835412&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B38">38. <span class="element-citation">Mao X, Bigham AW, Mei R, et al.  A genomewide admixture mapping panel for Hispanic/Latino populations. <span><span class="ref-journal">Am J Hum Genet. </span>2007;<span class="ref-vol">80</span>(6):1171–1178.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1867104/">PMC free article</a>]</span> [<a href="/pubmed/17503334" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=A+genomewide+admixture+mapping+panel+for+Hispanic/Latino+populations.&amp;author=X+Mao&amp;author=AW+Bigham&amp;author=R+Mei&amp;volume=80&amp;issue=6&amp;publication_year=2007&amp;pages=1171-1178&amp;pmid=17503334&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B39">39. <span class="element-citation">Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>2002;<span class="ref-vol">99</span>(10):6567–6572.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC124443/">PMC free article</a>]</span> [<a href="/pubmed/12011421" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;title=Diagnosis+of+multiple+cancer+types+by+shrunken+centroids+of+gene+expression.&amp;author=R+Tibshirani&amp;author=T+Hastie&amp;author=B+Narasimhan&amp;author=G+Chu&amp;volume=99&amp;issue=10&amp;publication_year=2002&amp;pages=6567-6572&amp;pmid=12011421&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B40">40. <span class="element-citation">Purcell S, Neale B, Todd-Brown K, et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. <span><span class="ref-journal">Am J Hum Genet. </span>2007;<span class="ref-vol">81</span>(3):559–575.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1950838/">PMC free article</a>]</span> [<a href="/pubmed/17701901" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=PLINK:+a+tool+set+for+whole-genome+association+and+population-based+linkage+analyses.&amp;author=S+Purcell&amp;author=B+Neale&amp;author=K+Todd-Brown&amp;volume=81&amp;issue=3&amp;publication_year=2007&amp;pages=559-575&amp;pmid=17701901&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B41">41. <span class="element-citation">Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. <span><span class="ref-journal">Lancet. </span>2013;<span class="ref-vol">381</span>(9881):1943–1955.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3816716/">PMC free article</a>]</span> [<a href="/pubmed/23523389" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Acute+lymphoblastic+leukaemia.&amp;author=H+Inaba&amp;author=M+Greaves&amp;author=CG+Mullighan&amp;volume=381&amp;issue=9881&amp;publication_year=2013&amp;pages=1943-1955&amp;pmid=23523389&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B42">42. <span class="element-citation">Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. <span><span class="ref-journal">Nat Rev Cancer. </span>2006;<span class="ref-vol">6</span>(3):193–203.</span> [<a href="/pubmed/16467884" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Cancer&amp;title=Infection,+immune+responses+and+the+aetiology+of+childhood+leukaemia.&amp;author=M+Greaves&amp;volume=6&amp;issue=3&amp;publication_year=2006&amp;pages=193-203&amp;pmid=16467884&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B43">43. <span class="element-citation">Greaves MF. Biological models for leukaemia and lymphoma. <span><span class="ref-journal">IARC Sci Publ. </span>2004;(157):351–372.</span> [<a href="/pubmed/15055306" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=IARC+Sci+Publ&amp;title=Biological+models+for+leukaemia+and+lymphoma.&amp;author=MF+Greaves&amp;issue=157&amp;publication_year=2004&amp;pages=351-372&amp;pmid=15055306&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B44">44. <span class="element-citation">Greaves M. Pre-natal origins of childhood leukemia. <span><span class="ref-journal">Rev Clin Exp Hematol. </span>2003;<span class="ref-vol">7</span>(3):233–245.</span> [<a href="/pubmed/15024967" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Rev+Clin+Exp+Hematol&amp;title=Pre-natal+origins+of+childhood+leukemia.&amp;author=M+Greaves&amp;volume=7&amp;issue=3&amp;publication_year=2003&amp;pages=233-245&amp;pmid=15024967&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B45">45. <span class="element-citation">Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. <span><span class="ref-journal">Nat Immunol. </span>2004;<span class="ref-vol">5</span>(2):133–139.</span> [<a href="/pubmed/14749784" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Immunol&amp;title=Age-related+changes+in+lymphocyte+development+and+function.&amp;author=PJ+Linton&amp;author=K+Dorshkind&amp;volume=5&amp;issue=2&amp;publication_year=2004&amp;pages=133-139&amp;pmid=14749784&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B46">46. <span class="element-citation">Rizo A, Vellenga E, de Haan G, Schuringa JJ. Signaling pathways in self-renewing hematopoietic and leukemic stem cells: do all stem cells need a niche? <span><span class="ref-journal">Hum Mol Genet. </span>2006;<span class="ref-vol">15</span>(Spec No 2):R210–R219.</span> [<a href="/pubmed/16987886" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Mol+Genet&amp;title=Signaling+pathways+in+self-renewing+hematopoietic+and+leukemic+stem+cells:+do+all+stem+cells+need+a+niche?&amp;author=A+Rizo&amp;author=E+Vellenga&amp;author=G+de+Haan&amp;author=JJ+Schuringa&amp;volume=15&amp;issue=Spec+No+2&amp;publication_year=2006&amp;pages=R210-R219&amp;pmid=16987886&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B47">47. <span class="element-citation">Lahoud MH, Ristevski S, Venter DJ, et al.  Gene targeting of Desrt, a novel ARID class DNA-binding protein, causes growth retardation and abnormal development of reproductive organs. <span><span class="ref-journal">Genome Res. </span>2001;<span class="ref-vol">11</span>(8):1327–1334.</span> [<a href="/pubmed/11483573" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genome+Res&amp;title=Gene+targeting+of+Desrt,+a+novel+ARID+class+DNA-binding+protein,+causes+growth+retardation+and+abnormal+development+of+reproductive+organs.&amp;author=MH+Lahoud&amp;author=S+Ristevski&amp;author=DJ+Venter&amp;volume=11&amp;issue=8&amp;publication_year=2001&amp;pages=1327-1334&amp;pmid=11483573&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B48">48. <span class="element-citation">Yagi R, Zhu J, Paul WE. An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiation. <span><span class="ref-journal">Int Immunol. </span>2011;<span class="ref-vol">23</span>(7):415–420.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3123974/">PMC free article</a>]</span> [<a href="/pubmed/21632975" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+Immunol&amp;title=An+updated+view+on+transcription+factor+GATA3-mediated+regulation+of+Th1+and+Th2+cell+differentiation.&amp;author=R+Yagi&amp;author=J+Zhu&amp;author=WE+Paul&amp;volume=23&amp;issue=7&amp;publication_year=2011&amp;pages=415-420&amp;pmid=21632975&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B49">49. <span class="element-citation">Zhang J, Ding L, Holmfeldt L, et al.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. <span><span class="ref-journal">Nature. </span>2012;<span class="ref-vol">481</span>(7380):157–163.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3267575/">PMC free article</a>]</span> [<a href="/pubmed/22237106" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=The+genetic+basis+of+early+T-cell+precursor+acute+lymphoblastic+leukaemia.&amp;author=J+Zhang&amp;author=L+Ding&amp;author=L+Holmfeldt&amp;volume=481&amp;issue=7380&amp;publication_year=2012&amp;pages=157-163&amp;pmid=22237106&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B50">50. <span class="element-citation">Enciso-Mora V, Broderick P, Ma Y, et al.  A genome-wide association study of Hodgkin’s lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). <span><span class="ref-journal">Nat Genet. </span>2010;<span class="ref-vol">42</span>(12):1126–1130.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4268499/">PMC free article</a>]</span> [<a href="/pubmed/21037568" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=A+genome-wide+association+study+of+Hodgkin’s+lymphoma+identifies+new+susceptibility+loci+at+2p16.1+(REL),+8q24.21+and+10p14+(GATA3).&amp;author=V+Enciso-Mora&amp;author=P+Broderick&amp;author=Y+Ma&amp;volume=42&amp;issue=12&amp;publication_year=2010&amp;pages=1126-1130&amp;pmid=21037568&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4304112&amp;issue-id=248247&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#idm139629809571568title">Key Points</a></li><li><a href="#idm139629799510944title">Abstract</a></li><li><a href="#__sec1title">Introduction</a></li><li><a href="#__sec2title">Methods</a></li><li><a href="#__sec8title">Results</a></li><li><a href="#__sec12title">Discussion</a></li><li><a href="#idm139629799710848title">Acknowledgments</a></li><li><a href="#idm139629805666160title">Footnotes</a></li><li><a href="#__sec13title">Authorship</a></li><li><a href="#idm139629797366192title">References</a></li></ul></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr>Articles from <span class="acknowledgment-journal-title">Blood</span> are provided here courtesy of <strong>The American Society of Hematology</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC4304112/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC4304112/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC4304112/?report=printable">Printer Friendly</a></li> | <li><a href="#" data-citationid="PMC4304112" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4304112%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4304112%2F&amp;text=A%20genome-wide%20association%20study%20of%20susceptibility%20to%20acute%20lymphoblastic%20leukemia%20in%20adolescents%20and%20young%20adults" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4304112%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="25468567" data-aiid="4304112" data-aid="4304112" data-iid="248247" data-domainid="446" data-domain="blood" data-accid="PMC4304112" data-md5="cbfe6c8d6f4c05d80c28970bcd6caf8e"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T13:02:06-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal105&amp;ncbi_phid=CE8CBD33DD57B0810000000002E101CB&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4304112%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=blood&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC4304112/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>